{"gene":"POMC","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":1980,"finding":"The human POMC genomic DNA encodes the corticotropin-β-lipotropin precursor as a single gene; nucleotide sequencing revealed pairs of basic amino acid residues (Lys-Arg) punctuating conserved segments corresponding to component peptide hormones ACTH and β-lipotropin, with no intervening sequence over the exon 3 region, establishing the structural basis for proteolytic processing.","method":"Genomic DNA isolation, electron microscope heteroduplex analysis, gel blotting, and nucleotide sequencing compared with bovine cDNA","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — direct sequencing of human genomic DNA with functional annotation of cleavage sites; foundational paper with 184 citations","pmids":["6254047"],"is_preprint":false},{"year":1983,"finding":"The human POMC gene was chromosomally localized to 2p23 by in situ hybridization, establishing its genomic map position.","method":"In situ hybridization to stretched prometaphase chromosomes with high-resolution banding","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — direct cytogenetic mapping; replicated in subsequent studies","pmids":["6196780"],"is_preprint":false},{"year":1983,"finding":"CRF stimulates ACTH secretion from anterior pituitary cells and α-MSH secretion from pars intermedia cells via adenylate cyclase activation at the pituitary level; α1-adrenergic agents stimulate ACTH directly at the pituitary, while β-adrenergic and antidopaminergic agents act suprapituitarily. Dopamine receptor activation inhibits pars intermedia activity.","method":"Primary culture of rat anterior and intermediate pituitary cells; adenylate cyclase assay; in vivo peptide measurements","journal":"Journal of steroid biochemistry","confidence":"High","confidence_rationale":"Tier 2 — in vitro cell-culture assay combined with in vivo validation, multiple signaling pathways tested","pmids":["6310240"],"is_preprint":false},{"year":1986,"finding":"ACTH and α-MSH peptides in the rat anterior pituitary are differentially stored in distinct secretory granule populations within corticotropes, as revealed by double-label immunocytochemistry; three subtypes of corticotropes were distinguished by their relative content of ACTH vs. α-MSH immunoreactivity.","method":"Double-labeling immunocytochemistry (ferritin for α-MSH; colloidal gold for ACTH) at the electron microscopy level","journal":"Cell and tissue research","confidence":"High","confidence_rationale":"Tier 2 — subcellular localization by electron-microscopic double immunolabeling with functional implication for differential secretion","pmids":["3004731"],"is_preprint":false},{"year":1986,"finding":"ACTH-(1-24) and α-MSH administered intracerebroventricularly suppress spontaneous feeding and abolish the feeding-stimulatory effect of κ-opioid receptor agonists, establishing that melanocortin peptides play an inhibitory role in a melanocortin-opioid homeostatic system with opposing, mutually-balancing effects.","method":"Intracerebroventricular injection in adult rats; behavioral measurement of food intake","journal":"Peptides","confidence":"Medium","confidence_rationale":"Tier 3 — pharmacological behavioral study with single method, but clear pathway antagonism demonstrated","pmids":["3025825"],"is_preprint":false},{"year":1987,"finding":"POMC-derived peptides (ACTH, β-endorphin, α-MSH) in brainstem baroreceptor areas of the rat originate from both hypothalamic arcuate nucleus neurons and local NTS neurons; surgical lesion and transection experiments defined two descending pathways (medial and lateral) through which hypothalamic POMC fibers innervate vasomotor centers.","method":"Radioimmunoassay of brainstem peptides; 10 types of surgical lesions/transections in rat; immunohistochemistry","journal":"Brain research","confidence":"High","confidence_rationale":"Tier 2 — multiple lesion approaches to map anatomical origins; well-controlled dissection study","pmids":["2829991"],"is_preprint":false},{"year":1988,"finding":"POMC gene is expressed in many rat non-pituitary tissues (testis, duodenum, kidney, colon, liver, lung, stomach, spleen) producing a shorter (~800 nt) POMC-like mRNA compared with the ~1000 nt pituitary POMC mRNA, and the resulting peptides are processed differently or turned over faster in peripheral tissues.","method":"Northern blot hybridization with exon 3 riboprobe; gel filtration chromatography; radioimmunoassay of ACTH, β-endorphin, γ-MSH","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (Northern blot, RIA, chromatography) across multiple tissues","pmids":["2836169"],"is_preprint":false},{"year":1989,"finding":"Glucocorticoid repression of POMC transcription is mediated by a negative glucocorticoid response element (nGRE) in the proximal POMC promoter that also binds COUP-family transcription factors; mutually exclusive binding of the glucocorticoid receptor and COUP factors to the nGRE determines cell-specific expression and glucocorticoid repression.","method":"DNA-mediated gene transfer into transgenic mice and tissue culture cells; DNA-protein binding assays","journal":"Genome","confidence":"High","confidence_rationale":"Tier 1 — promoter deletion analysis in vivo (transgenic mice) and in vitro, DNA-binding assays identifying specific regulatory element","pmids":["2698828"],"is_preprint":false},{"year":1989,"finding":"Peripheral γ-MSH peptides (derived from the N-terminal region of POMC) exert pressor, cardioaccelerator, and natriuretic effects dependent on central sympathetic drive and central vasopressinergic pathways; structure-activity studies identified the His-Phe-Arg-Trp core (γ-MSH-(5-8)/ACTH-(6-9)) as the minimal cardiovascular active sequence.","method":"Intravenous infusion with adrenergic/central lesion pharmacology in rats; structure-activity relationship with peptide fragments; intracarotid vs. intrajugular comparison","journal":"The American journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological structure-activity analysis with multiple peptide fragments and lesion studies","pmids":["2552843"],"is_preprint":false},{"year":1991,"finding":"ACTH-(1-24) competes with dopamine D2 receptor agonist [3H]NPA binding in rat striatal membranes in an apparent competitive manner (increased Kd, unchanged Bmax), and structure-activity analysis showed chain length is a key determinant of this interaction; ACTH peptides also inhibit D2 antagonist binding in pituitary, septum, and substantia nigra.","method":"Radioligand binding assays with rat striatal membranes; Scatchard analysis; structure-activity with multiple ACTH fragments","journal":"European journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro binding assay with Scatchard analysis and structure-activity series","pmids":["1680721"],"is_preprint":false},{"year":1992,"finding":"The murine and human melanocyte-stimulating hormone receptors (MC1R) and human ACTH receptor (MC2R) were cloned and identified as G-protein-coupled receptors; functional expression confirmed coupling to guanine nucleotide-binding proteins and defined the melanocortin receptor (MCR) subfamily.","method":"Molecular cloning, heterologous expression in cell lines, receptor binding assays","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 — gene cloning with functional receptor characterization; >1400 citations, foundational receptor identification","pmids":["1325670"],"is_preprint":false},{"year":1993,"finding":"A fourth human melanocortin receptor (MC4R), expressed primarily in the brain (absent from adrenal cortex, melanocytes, and placenta), was cloned and shown to increase intracellular cAMP upon agonist stimulation; its pharmacological profile distinguishes it from previously described MCRs.","method":"Molecular cloning, Northern blot, in situ hybridization, transient and stable transfection in COS-1 and L-cells, cAMP assay, fluorescent in situ hybridization (chromosome 18q21.3)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — gene cloning plus functional cAMP assay plus chromosomal localization; replicated by multiple groups","pmids":["8392067"],"is_preprint":false},{"year":1993,"finding":"A third human melanocortin receptor (MC3R) was cloned; pharmacological characterization showed it responds to the heptapeptide core common to ACTH and α-, β-, and γ-MSH with increased intracellular cAMP; expression is in brain, placenta, and gut but not melanoma cells or adrenal gland.","method":"PCR-based cloning, pharmacological characterization (receptor binding and cAMP assay), Northern blot and PCR expression analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — gene cloning with functional receptor assay; foundational study","pmids":["8463333"],"is_preprint":false},{"year":1993,"finding":"A novel human melanocortin receptor (MC2, later also designated MC-2) was cloned; when expressed in COS-7 cells it bound [125I]-NDP-MSH and was displaced by α-, β-, γ-MSH and ACTH but not β-endorphin, with highest affinity for NDP-MSH (Ki ~5 nM); receptor is expressed in brain.","method":"Genomic cloning, COS-7 cell expression, radioligand binding displacement assay","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — gene cloning with functional binding characterization","pmids":["8396929"],"is_preprint":false},{"year":1994,"finding":"The mouse MC5 receptor (mMC5R) was cloned and shown to couple to adenylyl cyclase (cAMP increase) upon melanocortin stimulation; potency hierarchy was α-MSH > β-MSH > ACTH > γ-MSH; N- and C-terminal portions of α-MSH, but not the core heptapeptide alone, are key for MC5R activation.","method":"PCR-based cloning, cAMP assay in transfected cells, structure-activity analysis, Northern blot","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — receptor cloning with functional cAMP assay and structure-activity dissection","pmids":["8185570"],"is_preprint":false},{"year":1994,"finding":"Structural modifications at Trp9 of ACTH (substitution with Phe or N-α-methyltryptophan) produce antagonists that bind the ACTH receptor with high affinity but fail to activate the adrenal cortical adenylate cyclase system, demonstrating that Trp9 is essential for receptor activation but not binding, and that receptor occupancy alone is insufficient for hormonal activity.","method":"In vitro adenylate cyclase assay with bovine adrenal cortical plasma membranes; structure-activity analysis with ACTH analogs","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assay with active-site mutagenesis equivalents (synthetic analogs), clearly dissociates binding from activation","pmids":["4359333"],"is_preprint":false},{"year":1996,"finding":"UVB radiation stimulates increased POMC gene expression accompanied by production and release of α-MSH and ACTH by normal and malignant human melanocytes and keratinocytes; this response is also stimulated by dbcAMP and IL-1α, and can be abolished by the free radical scavenger NAC, implicating a cyclic AMP-dependent pathway and oxidative stress in UVB-induced POMC peptide production.","method":"Cell culture of human melanocytes and keratinocytes; UVB irradiation; RIA for α-MSH and ACTH; pharmacological manipulation (dbcAMP, IL-1α, NAC)","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 — functional cell-culture assay with multiple stimuli and pharmacological blockade","pmids":["8781560"],"is_preprint":false},{"year":1997,"finding":"None of the melanocortin receptors MC1, MC3, MC4, or MC5 possess binding epitopes for ACTH beyond the α-MSH sequence; MC3R shows >10-fold higher affinity for ACTH peptides than MC4R and favors the desacetylated N-terminus, suggesting MC3R as the likely mediator of short-loop negative feedback by ACTH/MSH peptides on CRF release.","method":"Competitive radioligand binding assay on transiently transfected eukaryotic cells expressing individual MCRs, using 125I-[Nle4,D-Phe7]α-MSH","journal":"The Journal of endocrinology","confidence":"High","confidence_rationale":"Tier 2 — systematic binding assay across all four MCR subtypes with multiple ACTH fragment analogs","pmids":["9390008"],"is_preprint":false},{"year":1998,"finding":"Two human patients with compound heterozygous or homozygous mutations in POMC exons develop early-onset obesity, adrenal insufficiency, and red hair pigmentation, establishing POMC as a monogenic determinant of energy homeostasis, adrenal function, and skin/hair pigmentation in humans.","method":"POMC gene sequencing in patients; identification of mutations (G7013T, C7133Δ in exon 3; C3804A in exon 2) that impair ACTH and α-MSH synthesis or abolish POMC translation","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 — loss-of-function mutations with defined molecular mechanism and specific multi-organ phenotypic readout; >1200 citations","pmids":["9620771"],"is_preprint":false},{"year":1998,"finding":"The Arg151Cys variant of human MC1R binds α-MSH with normal affinity but cannot be stimulated to produce cAMP, rendering MC1R completely nonfunctional and explaining red hair, light skin, and poor tanning ability in affected individuals.","method":"Receptor binding with 131I-α-MSH; cAMP functional assay in transfected cells expressing Arg151Cys MC1R vs. wild-type","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — binding vs. signaling dissociation by site-specific natural mutation, functionally validated in vitro","pmids":["9571181"],"is_preprint":false},{"year":1999,"finding":"Desacetyl-α-MSH activates MC1, MC3, MC4, and MC5 receptors (EC50 0.13–0.84 nM) with comparable or greater potency to α-MSH; mouse agouti protein antagonizes desacetyl-α-MSH coupling to MC4R much more effectively than α-MSH coupling (with reduced Bmax and increased EC50), revealing differential antagonism depending on the N-terminal acetylation state of the ligand.","method":"Stable expression of individual MCRs in HEK293 cells; PKA signaling pathway assay; competitive antagonism with agouti protein","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1 — receptor pharmacology with quantitative dose-response and competitive antagonism analysis across multiple MCR subtypes","pmids":["10218968"],"is_preprint":false},{"year":1999,"finding":"Several common MC1R point mutations (Val60Leu, Arg142His, Arg151Cys, Arg160Trp, Asp294His) found in red-haired individuals lose the ability to stimulate cAMP in response to α-MSH without complete loss of ligand binding (Arg142His and Asp294His show slight reduction in binding affinity), demonstrating loss-of-function at the signaling level.","method":"Transfection of mutant MC1R constructs in COS-1 cells; radioligand binding; cAMP production assay","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis panel with binding and signaling assays; multiple mutants tested","pmids":["10403794"],"is_preprint":false},{"year":1999,"finding":"Chicken POMC gene was isolated as a single-copy gene with the same structural organization as mammalian POMC; the predicted 251 aa POMC contains nine proteolytic cleavage sites and can give rise to all melanocortin family members (ACTH, α-, β-, γ-MSH) and β-endorphin; POMC mRNA is expressed in brain, adrenal gland, gonads, kidney, uropygial gland, and adipose tissue.","method":"Genomic library screening, molecular cloning, sequence analysis, RT-PCR expression profiling","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — gene cloning with sequence-predicted cleavage sites confirmed by comparative analysis; ortholog study","pmids":["10395956"],"is_preprint":false},{"year":2002,"finding":"A missense mutation R236G in POMC disrupts the dibasic cleavage site between β-MSH and β-endorphin; cells transfected with mutant POMC produce a β-MSH/β-endorphin fusion protein that binds hMC4R with normal affinity but has markedly reduced ability to activate it, establishing a novel mechanism of obesity susceptibility through production of an aberrant POMC product that interferes with melanocortin signaling.","method":"POMC gene sequencing in 262 obese subjects; transfection of mutant POMC cDNA in β-TC3 cells; metabolic labeling; receptor binding and cAMP assay with hMC4R","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 — mutant protein production confirmed biochemically, receptor binding vs. activation dissection in vitro, co-segregation in family","pmids":["12165561"],"is_preprint":false},{"year":2003,"finding":"Leptin stimulates POMC gene transcription via activation of STAT3; leptin-induced POMC promoter activity requires the STAT3-binding site (Tyr1138) of the leptin receptor ObRb and a defined 30-bp promoter element; approximately 37% of hypothalamic POMC neurons (concentrated in the rostral region) show leptin-induced STAT3 phosphorylation.","method":"POMC promoter reporter assays in transfected cells; dominant-negative STAT3 expression; ObRb Tyr1138 mutant; double immunohistochemistry for phospho-STAT3 and POMC in rat hypothalamus","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (reporter assay, dominant negative, mutant receptor, in vivo immunohistochemistry) in two systems","pmids":["12697721"],"is_preprint":false},{"year":2003,"finding":"α-MSH and desacetyl-α-MSH similarly couple overexpressed MC1, MC3, MC4, and MC5 receptors to both adenylyl cyclase and calcium signaling pathways in HEK293 cells; however, α-MSH (but not desacetyl-α-MSH) significantly increases primary rat osteoblast proliferation, revealing a functional divergence at endogenous (low) receptor expression levels.","method":"Stably expressed MCRs in HEK293 cells; adenylyl cyclase assay; calcium signaling assay; primary osteoblast proliferation assay","journal":"Annals of the New York Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 — two signaling pathways measured with multiple MCR subtypes; divergent result in primary cells with endogenous receptors","pmids":["12851298"],"is_preprint":false},{"year":2005,"finding":"NPY inhibits posttranslational processing of POMC to active α-MSH by reducing prohormone convertase-2 (PC2) levels in ARC neurons; this is mediated through NPY-Y1 receptors and the transcription factor Egr-1. NPY also decreases α-MSH-induced CREB phosphorylation in the PVN, reducing TRH production, and decreases the amount of α-MSH delivered to PVN neurons.","method":"In vivo NPY injection; PC2 mRNA and protein measurements; Egr-1 knockdown; CREB phosphorylation assay; α-MSH and TRH measurements in hypothalamic nuclei","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal in vivo and molecular assays identifying a post-translational processing mechanism","pmids":["23321476"],"is_preprint":false},{"year":2005,"finding":"CRH stimulates cAMP, POMC gene expression, ACTH production and release, and corticosterone production in human dermal fibroblasts (but not keratinocytes), demonstrating a functional cutaneous CRH-POMC-corticosteroid axis equivalent to the HPA axis.","method":"Primary human fibroblast and keratinocyte cultures; cAMP assay; POMC mRNA and protein measurement; ELISA for corticosterone","journal":"Journal of neuroimmunology","confidence":"High","confidence_rationale":"Tier 2 — multiple assays (cAMP, mRNA, protein, hormone output) in primary human cells with appropriate cell-type controls","pmids":["15833364"],"is_preprint":false},{"year":2005,"finding":"LXRα positively regulates the POMC gene promoter at the transcriptional level; the RXRα/LXRα heterodimer binds the region between -73 and -52 bp of the rat POMC promoter; LXR agonist TO901317 increased POMC mRNA, ACTH immunoreactivity in pituitary, and plasma ACTH/corticosterone in vivo.","method":"Luciferase reporter assay; siRNA knockdown of LXRα; EMSA (electrophoretic mobility shift assay); chromatin immunoprecipitation (ChIP); in vivo mouse experiments","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 1 — EMSA with specific binding site mutants, ChIP confirmation, functional reporter assay, and in vivo validation","pmids":["19036902"],"is_preprint":false},{"year":2008,"finding":"Two novel heterozygous missense mutations in the POMC N-terminus (C28F and L37F) impair sorting of POMC to the regulated secretory pathway, redirecting mutant POMC to the constitutive secretory pathway, thereby preventing normal propeptide processing to bioactive melanocortin products and causing early-onset obesity.","method":"Metabolic labeling, Western blotting, immunoassay of lysates and conditioned media of transiently transfected β-TC3 cells; comparison of wild-type vs. mutant POMC processing and secretion","journal":"The Journal of clinical endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 1 — mechanistic in vitro experiments with metabolic labeling and secretion analysis distinguishing regulated vs. constitutive pathways","pmids":["18697863"],"is_preprint":false},{"year":2010,"finding":"POMC neuron-specific deletion of PTP1B reduces adiposity, improves leptin sensitivity, and increases energy expenditure on high-fat diet; POMC neuron-specific deletion of SHP2 produces opposite effects (increased adiposity, decreased leptin sensitivity, reduced energy expenditure) and markedly reduces hypothalamic POMC mRNA and α-MSH peptide levels, demonstrating that PTP1B and SHP2 reciprocally regulate energy balance via POMC neurons.","method":"Conditional (Cre-lox) POMC neuron-specific knockout mice for Ptp1b and Shp2; body composition measurement; hyperinsulinemic-euglycemic clamp; hypothalamic POMC mRNA and α-MSH peptide quantification","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — reciprocal genetic loss-of-function with multiple metabolic and molecular phenotypic readouts","pmids":["20160350"],"is_preprint":false},{"year":2013,"finding":"Pharmacogenetic (DREADD) activation of NTS POMC neurons acutely inhibits feeding within minutes, while ARC POMC neurons require chronic stimulation to suppress food intake; ablation of ARC but not NTS POMC neurons with diphtheria toxin increases food intake, reduces energy expenditure, and causes obesity and endocrine disorders, demonstrating distinct temporal and functional roles for POMC neurons in the two brain regions.","method":"Cre-dependent AAV delivery of hM3Dq DREADD or diphtheria toxin receptor to ARC vs. NTS POMC neurons in POMC-Cre mice; clozapine-N-oxide administration; diphtheria toxin ablation; food intake and energy expenditure measurement","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — DREADD activation and toxin-mediated ablation with specific stereotaxic targeting, multiple metabolic phenotypes measured","pmids":["23426689"],"is_preprint":false},{"year":2014,"finding":"MeCP2 positively regulates hypothalamic Pomc expression by preventing promoter DNA hypermethylation; deletion of MeCP2 in POMC neurons increases DNA methylation of the Pomc promoter and reduces POMC expression, causing obesity and leptin resistance. In vitro, hypermethylation of the Pomc promoter reduces transcriptional activity, and MeCP2 acts synergistically with CREB1 to activate the Pomc promoter.","method":"POMC-neuron-specific MeCP2 knockout mice; bisulfite sequencing of Pomc promoter; luciferase reporter assay with methylated promoter; co-transfection with MeCP2 and CREB1; metabolic phenotyping","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with methylation mapping, in vitro reporter assays, and metabolic phenotyping; multiple orthogonal methods","pmids":["24078059"],"is_preprint":false},{"year":2014,"finding":"Early-life stress (maternal separation) reduces DNA methylation at a critical regulatory region (-417 to -260 bp) of the Pomc promoter in mouse pituitary, leading to increased Pomc mRNA that persists for up to 1 year. Methyl-CpG binding protein-2 (MeCP2) binds the distal Pomc promoter and acts with HDAC2 and DNMT1 to repress Pomc expression under basal conditions.","method":"Early-life stress model in mice; bisulfite sequencing; MeCP2 binding assay; AtT20 cell line with site-specific Pomc promoter methylation; co-immunoprecipitation of MeCP2 with HDAC2 and DNMT1","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 — in vivo epigenetic analysis, confirmed in pituitary cell line with site-specific methylation and protein interaction studies","pmids":["24506071"],"is_preprint":false},{"year":2015,"finding":"FoxO1 inhibits STAT3-mediated leptin induction of POMC transcription through direct protein-protein interaction with STAT3; residues Gly140-Leu160 (specifically Gln145, Arg147, Lys148, Arg153, Arg154) of FoxO1 are critical for STAT3 binding; FoxO3 (but not FoxO4) similarly interacts with STAT3 and inhibits POMC promoter activity.","method":"Co-immunoprecipitation; FoxO1 deletion mutant analysis; POMC promoter luciferase assay; STAT3 binding mutants; computational docking simulation","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 — biochemical interaction mapping with deletion and point mutants, functional promoter assay, and structural modeling","pmids":["25510553"],"is_preprint":false},{"year":2015,"finding":"GPR45 regulates POMC expression via the JAK/STAT signaling pathway in a cell-autonomous manner; disruption of Gpr45 in mice reduces POMC expression and energy expenditure; intraventricular melanotan-2 (α-MSH analog) rescues adult obesity in Gpr45 mutants, placing GPR45 upstream of POMC in the melanocortin energy-balance pathway.","method":"piggyBac insertional mutagenesis screen; conditional Gpr45 disruption; POMC expression measurement; JAK/STAT pathway analysis; intracerebroventricular drug administration; metabolic phenotyping","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with pathway analysis (JAK/STAT), cell-autonomous validation, and pharmacological rescue","pmids":["27500489"],"is_preprint":false},{"year":2015,"finding":"Hypothalamic Kiss1 (kisspeptin) neurons, which regulate fertility and puberty onset, arise developmentally from POMC-expressing progenitors; using intersectional ribosome-tagging strategies in mice, Pomc-expressing precursors were shown to give rise to both energy-sensing POMC/AgRP neurons and reproductive Kiss1 neurons.","method":"Intersectional Cre-lox (embryonic and adult ribosome-tagging) transgenic mouse strategy; lineage tracing from Pomc-expressing progenitors; cell-type specific translational profiling","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic lineage tracing with dual reporter strategy, clean developmental pathway assignment","pmids":["25855171"],"is_preprint":false},{"year":2015,"finding":"Metformin induces AMPK/LXRα phosphorylation followed by suppression of POMC expression in rat pituitary cells, leading to reduced ACTH and cortisol levels; this AMPK/LXRα/POMC pathway was confirmed in animal studies as a molecular mechanism underlying the antihyperglycemic effect of metformin.","method":"Urinary metabolomics in human subjects; in vitro rat pituitary cell treatment with metformin; AMPK and LXRα phosphorylation assays; POMC/ACTH measurement; in vivo rat experiments","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo mechanistic evidence but single lab; pathway confirmed with phosphorylation assays","pmids":["25634597"],"is_preprint":false},{"year":2016,"finding":"E2F1 (phosphorylated at Ser-337) binds a cluster site in the proximal hPOMC promoter region (-42 to +68) and, together with its heterodimer partner DP1, drives ectopic hPOMC transcription in non-pituitary tumor cells independently of pituitary-specific Tpit/Pitx1 factors; inhibitors of E2F1 suppressed hPOMC expression and ACTH in vitro and in xenografted mice.","method":"POMC promoter reporter assays; E2F1/DP1 co-expression; ChIP for E2F1 binding; phosphorylation analysis (Ser-337); E2F1 inhibitors; xenograft mouse model; primary tumor cells","journal":"Endocrine-related cancer","confidence":"High","confidence_rationale":"Tier 2 — ChIP with promoter reporter assays and in vivo xenograft validation, multiple orthogonal methods","pmids":["27935805"],"is_preprint":false},{"year":2016,"finding":"Glutamatergic ARC neurons expressing the oxytocin receptor rapidly cause satiety when optogenetically/chemogenetically activated; their projections converge with GABAergic AgRP projections on MC4R-expressing PVH neurons (PVHMC4R). Transmission across the ARCGlutamatergic→PVHMC4R synapse is potentiated by α-MSH (derived from ARCPOMC neurons) acting as an MC4R agonist, revealing post-synaptic modulation of a satiety circuit by POMC-derived α-MSH.","method":"Optogenetics and chemogenetics (DREADD); electrophysiology; circuit tracing; MC4R-Cre conditional mouse lines; synaptic physiology recording before and after α-MSH application","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal circuit-tracing, optogenetic, and electrophysiological approaches; α-MSH role confirmed with pharmacology","pmids":["27869800"],"is_preprint":false},{"year":2016,"finding":"IRE1α in POMC neurons is required for thermogenesis and glycemia; POMC-specific Ire1α deficiency accelerates diet-induced obesity, impairs thermogenic responses and beiging of white adipose tissue, and causes whole-body glucose and insulin intolerance and hepatic insulin resistance; loss of Ire1α elevates ER stress and promotes leptin and insulin resistance in POMC neurons.","method":"Conditional Ire1α knockout in POMC neurons; metabolic phenotyping (energy expenditure, glucose/insulin tolerance tests, hepatic insulin sensitivity); hypothalamic ER stress markers","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — clean cell-type-specific genetic KO with multiple metabolic and cellular phenotypic endpoints","pmids":["28028078"],"is_preprint":false},{"year":2017,"finding":"TrpC5 channel subunits in POMC neurons mediate the acute anorexigenic effects of leptin and serotonin 2C receptor agonists; POMC-specific or neuronal TrpC5 deletion reduces energy expenditure, increases food intake, and blunts electrophysiological responses of arcuate POMC neurons to leptin and 5-HT2CR agonists, and blocks lorcaserin-induced glucose/insulin tolerance improvements.","method":"Conditional TrpC5 KO in POMC neurons; electrophysiology (patch-clamp) of arcuate POMC neurons; pharmacological challenge with leptin and 5-HT2CR agonist lorcaserin; metabolic phenotyping","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with electrophysiological and metabolic phenotyping; receptor pharmacology validated","pmids":["28099839"],"is_preprint":false},{"year":2017,"finding":"In diet-induced obese mice, persistently activated microglia hypersecrete TNFα which stimulates mitochondrial ATP production and fusion in POMC neuron neurites, increasing POMC neuronal firing rates and excitability; disruption of TNFα downstream signals TNFSF11A or NDUFAB1 in the mediobasal hypothalamus reverses mitochondrial elongation and reduces obesity.","method":"Diet-induced obesity mouse model; microglial activation characterization; TNFα measurement; mitochondrial morphology imaging in POMC neurons; electrophysiology; targeted gene disruption (TNFSF11A, NDUFAB1)","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — mechanistic pathway from microglia→TNFα→mitochondrial fusion→POMC excitability, multiple orthogonal methods","pmids":["28489068"],"is_preprint":false},{"year":2017,"finding":"DRP1-mediated mitochondrial fission in POMC neurons restrains leptin sensitivity and glucose sensing; inducible deletion of DRP1 in mature POMC neurons increases mitochondrial size, ROS production, and neuronal activation, improves leptin sensitivity and glucose responsiveness, and enhances glucoprivic counter-regulatory responses via PPAR-dependent upregulation of Kcnj11 (KATP channel subunit).","method":"Inducible conditional DRP1 KO in POMC neurons (Drp1fl/fl-POMC-cre:ERT2); mitochondrial morphology analysis; electrophysiology; leptin and glucose challenge assays; gene expression (Kcnj11, PPAR pathway)","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 — inducible conditional KO with mechanistic follow-up (ROS, PPAR pathway, Kcnj11) and electrophysiological readout","pmids":["28190775"],"is_preprint":false},{"year":2017,"finding":"ATF4 in POMC neurons directly binds the ATG5 promoter and represses ATG5 transcription; loss of ATF4 in POMC neurons upregulates ATG5-dependent macroautophagy and increases α-MSH production in the hypothalamus, leading to a lean phenotype resistant to diet-induced obesity. Double KO of Atf4 and Atg5 in POMC neurons reverses the lean phenotype, placing ATG5/autophagy downstream of ATF4 as a mechanism regulating α-MSH production.","method":"POMC-neuron-specific Atf4 KO; double Atf4/Atg5 KO; ATF4 ChIP at ATG5 promoter; autophagy flux assays; α-MSH measurement; metabolic phenotyping","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 — epistasis by double KO, ChIP for direct promoter binding, functional α-MSH output assay","pmids":["28350524"],"is_preprint":false},{"year":2018,"finding":"A subpopulation of POMC neurons is activated by insulin via insulin receptor signaling, and represses hepatic glucose production (HGP); the proportion of POMC neurons activated by insulin is regulated by the phosphatase TCPTP, which is increased by fasting and degraded after feeding. Elevated TCPTP in obesity represses insulin-induced activation of POMC neurons and their ability to suppress HGP.","method":"POMC-neuron-specific TCPTP deletion in mice; electrophysiology of POMC neurons; hepatic glucose production measurement (hyperinsulinemic-euglycemic clamp); TCPTP protein level analysis in obesity and fasting/fed states","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with electrophysiology, clamp studies, and mechanistic TCPTP regulation defined","pmids":["30230471"],"is_preprint":false},{"year":2021,"finding":"POMCLepr+ and POMCGlp1r+ neuron subpopulations in the arcuate nucleus are largely nonoverlapping, exhibit distinct electrophysiological properties and anatomical distributions, differentially express receptors for energy-state hormones and neurotransmitters, and differ in their ability to suppress feeding, revealing a functional microarchitecture of POMC neurons.","method":"Intersectional Cre/Dre-dependent mouse models for labeling specific POMC subpopulations; translational profiling (RiboTag); electrophysiology; chemogenetic feeding assays","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 — intersectional genetic approach with electrophysiology, transcriptomics, and functional feeding assays across two distinct subpopulations","pmids":["34002087"],"is_preprint":false},{"year":2021,"finding":"mTORC1 blockade in POMC neurons induces hyperphagia by mimicking a cellular negative energy state; this is associated with decreased α-MSH production, recruitment of POMC/GABAergic neurotransmission (restrained by cannabinoid type 1 receptor), and simultaneous activation of POMC/GABAergic neurons and inhibition of POMC/glutamatergic neurons, revealing mTORC1 as an orchestrator of functionally distinct POMC neuron subpopulations.","method":"Conditional mTORC1 (Raptor) KO in POMC neurons; chemogenetics; electrophysiology; optogenetics; α-MSH measurement; translational profiling and single-cell analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (conditional KO, chemogenetics, optogenetics, electrophysiology, α-MSH assay)","pmids":["34644574"],"is_preprint":false},{"year":2021,"finding":"In diabetic mice, NF-κB p50 subunit binding to the Pomc promoter represses POMC expression in sensory neurons; decreased POMC leads to lysosomal degradation of μ-opioid receptor (MOR), impairing antinociception; viral overexpression of POMC and MOR in sensory ganglia rescues the neuropathic pain phenotype.","method":"Streptozotocin diabetic mouse model; ChIP for NF-κB p50 at Pomc promoter; peripheral nerve POMC level measurement; MOR degradation analysis; AAV-mediated overexpression of POMC and MOR in sensory ganglia; behavioral pain assays; validation in human diabetic peripheral nervous system tissue","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — ChIP identifies molecular mechanism (NF-κB p50 repression), validated in vivo by viral rescue, and corroborated in human tissue","pmids":["33462216"],"is_preprint":false},{"year":2021,"finding":"L-Lactate activates hypothalamic POMC neurons via two mechanisms: (1) through HCAR1 (hydroxycarboxylic acid receptor 1) on astrocytes coupled to Gαi/o-protein, mediating intercellular signaling to POMC neurons; and (2) via intracellular action blocked by the lactate transporter inhibitor 4-CIN in a subset of POMC neurons; depolarization in both cases is pertussis toxin-sensitive.","method":"Patch-clamp electrophysiology of labeled POMC neurons; pharmacological dissection with PTX, 4-CIN, APJ receptor antagonist, HCAR1 agonist 3Cl-HBA; immunohistochemical localization of HCAR1 to astrocytes not POMC neurons","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — electrophysiology with pharmacological dissection; novel mechanism (astrocyte HCAR1→POMC neuron signaling) identified but single lab","pmids":["34737351"],"is_preprint":false},{"year":2020,"finding":"Optogenetic activation of the ARCPOMC→MeA (medial amygdala) neural projection reduces short-term food intake; anterograde tracing shows ARC POMC neurons project to ER-α- and MC4R-expressing neurons in the MeA; the anorectic effect of ARCPOMC→MeA stimulation is blocked by the MC4R antagonist SHU9119, establishing a functional extrahypothalamic melanocortinergic satiety circuit.","method":"Optogenetics (ChR2); monosynaptic anterograde and retrograde viral tracing; double immunohistochemistry for MC4R and ER-α; MC4R antagonist pharmacology; food intake measurement","journal":"Frontiers in neural circuits","confidence":"High","confidence_rationale":"Tier 2 — optogenetics combined with circuit tracing and pharmacological validation","pmids":["33250721"],"is_preprint":false},{"year":2015,"finding":"Apelin-13 depolarizes approximately half of arcuate POMC neurons in a dose-dependent manner via the APJ receptor; this effect is mediated by Gβγ-dependent activation of PLC-β signaling (not Gαi/o) that inhibits M-type current (KCNQ channels 2, 3, 5); pertussis toxin does not block the response, but the Gβγ inhibitor gallein and PLC/PKC inhibitors do.","method":"Electrophysiology (patch-clamp); single-cell qPCR for APJ receptor and KCNQ subunits; pharmacological dissection with APJ antagonist, pertussis toxin, gallein, PLC/PKC inhibitors; M-current measurement","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — electrophysiology with rigorous pharmacological dissection and single-cell receptor expression confirmation","pmids":["25782002"],"is_preprint":false}],"current_model":"POMC is a precursor polypeptide processed in a tissue-specific manner by prohormone convertases at dibasic cleavage sites to generate biologically active melanocortin peptides (α-, β-, γ-MSH, ACTH) and β-endorphin; POMC transcription is driven by tissue-specific regulators (Tpit/Pitx1 in pituitary, E2F1 in ectopic tumors), stimulated by CRF/STAT3/LXRα/leptin-STAT3 signaling, and repressed by glucocorticoids via an nGRE and by FoxO1-mediated blockade of STAT3, DNA methylation (regulated by MeCP2 and NF-κB p50), and ATF4; in hypothalamic POMC neurons, hormonal inputs (leptin via STAT3, insulin via IR/TCPTP, serotonin via TrpC5, apelin via APJ/Gβγ/KCNQ, lactate via astrocyte HCAR1) converge on neuronal excitability to control energy homeostasis through release of α-MSH that activates MC3R/MC4R on downstream neurons (including in the PVH and MeA) to suppress feeding, while mitochondrial dynamics (DRP1-dependent fission, TNFα-driven fusion) and mTORC1 within functionally distinct POMC neuron subpopulations further tune their activity and neurotransmitter output."},"narrative":{"teleology":[{"year":1980,"claim":"Sequencing the human POMC gene revealed a single-gene precursor architecture with dibasic residue cleavage sites demarcating ACTH and β-lipotropin segments, establishing the structural basis for tissue-specific proteolytic processing into multiple bioactive peptides.","evidence":"Genomic DNA sequencing with heteroduplex analysis and comparison to bovine cDNA","pmids":["6254047"],"confidence":"High","gaps":["Processing enzymes not yet identified","Tissue-specific processing rules not defined"]},{"year":1983,"claim":"CRF was identified as a physiological stimulus of POMC-derived peptide secretion from anterior pituitary via adenylate cyclase, while dopamine inhibits intermediate lobe output, defining the hormonal inputs controlling POMC product release at the pituitary level.","evidence":"Primary culture of rat anterior and intermediate pituitary cells with cAMP assay and in vivo peptide measurements","pmids":["6310240"],"confidence":"High","gaps":["Intracellular signaling cascade from CRF to POMC transcription not mapped","Relative contribution of cAMP vs. other second messengers unclear"]},{"year":1986,"claim":"Central administration of ACTH and α-MSH suppressed feeding and antagonized κ-opioid-stimulated intake, establishing the concept of opposing melanocortin–opioid systems in energy homeostasis before melanocortin receptors were cloned.","evidence":"Intracerebroventricular injection of melanocortin peptides in rats with behavioral food-intake measurement","pmids":["3025825"],"confidence":"Medium","gaps":["Receptor identity unknown at the time","Pharmacological approach cannot distinguish direct vs. indirect effects"]},{"year":1989,"claim":"Identification of a negative glucocorticoid response element (nGRE) in the proximal POMC promoter, where mutually exclusive binding of the glucocorticoid receptor and COUP-family factors determines glucocorticoid repression and cell-specific expression, established the first cis-regulatory logic for POMC transcription.","evidence":"Promoter deletion analysis in transgenic mice and cell culture with DNA-protein binding assays","pmids":["2698828"],"confidence":"High","gaps":["Full set of transcription factors driving pituitary-specific expression not defined","Chromatin context of nGRE occupancy not addressed"]},{"year":1992,"claim":"Cloning of MC1R–MC5R defined the receptor family through which POMC-derived melanocortins signal, each coupling to adenylyl cyclase/cAMP, and revealed tissue-specific receptor expression explaining how a single precursor generates diverse physiological outputs.","evidence":"Molecular cloning with heterologous expression, binding assays, and cAMP signaling in transfected cells","pmids":["1325670","8392067","8463333","8185570"],"confidence":"High","gaps":["Non-cAMP signaling pathways of MCRs incompletely characterized","Endogenous receptor stoichiometry and functional selectivity not addressed"]},{"year":1998,"claim":"Identification of compound heterozygous/homozygous POMC mutations in patients with early-onset obesity, adrenal insufficiency, and red hair provided the first human genetic proof that POMC is essential for energy homeostasis, adrenal function, and pigmentation.","evidence":"POMC gene sequencing in patients with defined multi-organ phenotype","pmids":["9620771"],"confidence":"High","gaps":["Genotype-phenotype correlation across a range of POMC mutations incomplete","Relative contribution of individual POMC products to each phenotype unknown"]},{"year":2002,"claim":"Discovery that R236G disrupts a dibasic cleavage site to produce an aberrant β-MSH/β-endorphin fusion protein that binds MC4R but cannot activate it revealed that impaired POMC processing—not just absence of POMC—can cause obesity through generation of a dominant-negative-like melanocortin product.","evidence":"Metabolic labeling and receptor binding/cAMP assay with mutant POMC in transfected β-TC3 cells","pmids":["12165561"],"confidence":"High","gaps":["Prevalence of processing-site mutations in broader obese populations unknown","Whether the fusion protein acts as a true competitive antagonist in vivo is unresolved"]},{"year":2003,"claim":"Leptin was shown to stimulate POMC transcription via STAT3, requiring Tyr1138 of the leptin receptor and a specific POMC promoter element, providing the molecular link between peripheral adiposity signals and hypothalamic melanocortin output.","evidence":"POMC promoter reporter assays, dominant-negative STAT3, ObRb mutant, and phospho-STAT3/POMC double immunohistochemistry in rat hypothalamus","pmids":["12697721"],"confidence":"High","gaps":["Only ~37% of POMC neurons showed leptin-STAT3 activation; identity and regulation of the non-responding majority unclear","Other leptin-activated pathways in POMC neurons not dissected"]},{"year":2008,"claim":"N-terminal POMC mutations (C28F, L37F) were shown to redirect POMC from the regulated to the constitutive secretory pathway, preventing proper processing and causing obesity—establishing that signal-peptide-region integrity is required for POMC sorting to secretory granules.","evidence":"Metabolic labeling and Western blot of wild-type vs. mutant POMC secretion in β-TC3 cells","pmids":["18697863"],"confidence":"High","gaps":["Sorting receptor or chaperone that recognizes the POMC N-terminus not identified","Whether constitutively secreted unprocessed POMC has any signaling activity is unknown"]},{"year":2014,"claim":"Epigenetic regulation of POMC was defined: MeCP2 prevents promoter DNA hypermethylation and cooperates with CREB1 to activate POMC transcription in hypothalamic neurons, while in pituitary, MeCP2 complexes with HDAC2/DNMT1 to repress POMC—revealing tissue-specific epigenetic gating of POMC expression.","evidence":"POMC-neuron-specific MeCP2 KO mice; bisulfite sequencing; luciferase assays with methylated promoter; co-IP of MeCP2/HDAC2/DNMT1 in pituitary cells","pmids":["24078059","24506071"],"confidence":"High","gaps":["How MeCP2 switches between activator and repressor roles in different tissues is mechanistically unresolved","Contribution of other chromatin remodelers not assessed"]},{"year":2016,"claim":"α-MSH was shown to act as a postsynaptic neuromodulator at MC4R-expressing PVH neurons, potentiating glutamatergic satiety transmission from ARC to PVH, and a separate ARCPOMC→MeA projection was identified as an extrahypothalamic melanocortinergic satiety circuit.","evidence":"Optogenetics, chemogenetics, electrophysiology, and MC4R antagonist pharmacology in circuit-specific mouse models","pmids":["27869800","33250721"],"confidence":"High","gaps":["Relative contribution of PVH vs. MeA projection to overall satiety unclear","Neuropeptide vs. fast neurotransmitter release from POMC neurons not fully dissected"]},{"year":2017,"claim":"Mitochondrial dynamics within POMC neurons emerged as a cell-intrinsic rheostat: TNFα-driven mitochondrial fusion increases POMC neuron excitability in obesity, while DRP1-mediated fission restrains leptin sensitivity and glucose sensing, with mTORC1 orchestrating functionally distinct GABAergic and glutamatergic POMC neuron subpopulations.","evidence":"Conditional KO of DRP1 and Raptor in POMC neurons; microglial TNFα and mitochondrial morphology imaging; electrophysiology; optogenetics and chemogenetics","pmids":["28489068","28190775","34644574"],"confidence":"High","gaps":["How mitochondrial dynamics interface with POMC processing machinery is unknown","Whether mitochondrial fission/fusion directly affects α-MSH vesicle packaging is untested"]},{"year":2017,"claim":"Multiple ion channel and receptor mechanisms controlling POMC neuron excitability were defined: TrpC5 channels mediate leptin and serotonin 2C receptor-driven depolarization, while apelin acts via APJ/Gβγ/PLC-β to inhibit KCNQ M-type currents, establishing the electrophysiological integration point for diverse hormonal inputs.","evidence":"Conditional TrpC5 KO in POMC neurons with patch-clamp; pharmacological dissection of apelin signaling in POMC neurons with Gβγ inhibitor gallein and PLC/PKC inhibitors","pmids":["28099839","25782002"],"confidence":"High","gaps":["Full ion channel repertoire of POMC neuron subpopulations not cataloged","Whether TrpC5 and KCNQ pathways converge in the same POMC neurons is unknown"]},{"year":2018,"claim":"The phosphatase TCPTP was identified as a fasting/feeding-regulated brake on insulin signaling in POMC neurons: elevated in fasting and obesity, TCPTP dephosphorylates the insulin receptor to silence insulin-responsive POMC neurons and their suppression of hepatic glucose production.","evidence":"POMC-neuron-specific TCPTP deletion with electrophysiology and hyperinsulinemic-euglycemic clamp studies","pmids":["30230471"],"confidence":"High","gaps":["TCPTP targets beyond the insulin receptor in POMC neurons not mapped","How TCPTP is degraded upon feeding is mechanistically undefined"]},{"year":2021,"claim":"Intersectional genetic approaches revealed that POMCLepr+ and POMCGlp1r+ neuron subpopulations are largely nonoverlapping, with distinct electrophysiological properties and differential capacity to suppress feeding, establishing a functional microarchitecture within the POMC neuron population.","evidence":"Intersectional Cre/Dre mouse models with RiboTag translational profiling, electrophysiology, and chemogenetic feeding assays","pmids":["34002087"],"confidence":"High","gaps":["Full molecular taxonomy of POMC neuron subtypes across brain regions incomplete","How subpopulation-specific outputs are integrated at downstream targets is undefined"]},{"year":null,"claim":"Key unresolved questions include how POMC neuron subpopulation-specific neurotransmitter release (GABA vs. glutamate vs. α-MSH) is coordinately regulated, whether mitochondrial dynamics directly control POMC processing and peptide packaging, and the identity of sorting receptors that direct POMC to the regulated secretory pathway.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Sorting receptor for POMC into secretory granules not identified","Structural basis of POMC–prohormone convertase interaction unknown","Integration rules across POMC neuron subpopulations at downstream target neurons undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[4,10,11,12,14,17,20,39]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[3,16,27,29]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[3,29]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[10,11,12,14,17,20,24,39,41,51]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,23,26,29]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[5,31,39,41,46,50]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[30,40,43,45]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[16,48]}],"complexes":[],"partners":["MC1R","MC3R","MC4R","STAT3","MECP2","PCSK2","FOXO1","TRPC5"],"other_free_text":[]},"mechanistic_narrative":"POMC encodes a polyprotein precursor that is proteolytically processed at dibasic cleavage sites by prohormone convertases in a tissue-specific manner to yield melanocortin peptides (ACTH, α-MSH, β-MSH, γ-MSH) and β-endorphin, which act through a family of five G-protein-coupled melanocortin receptors (MC1R–MC5R) to regulate adrenal steroidogenesis, skin/hair pigmentation, energy homeostasis, and nociception [PMID:6254047, PMID:1325670, PMID:8392067]. In hypothalamic arcuate nucleus POMC neurons, leptin–STAT3, insulin–IR/TCPTP, serotonin–TrpC5, and apelin–APJ/Gβγ/KCNQ signaling pathways converge on neuronal excitability and α-MSH release, which activates MC4R on downstream PVH and MeA neurons to suppress feeding and modulate hepatic glucose production [PMID:12697721, PMID:28099839, PMID:30230471, PMID:27869800, PMID:33250721]. POMC transcription is driven by Tpit/Pitx1 in the pituitary and by E2F1/DP1 in ectopic tumors, stimulated by CRF and LXRα, and repressed by glucocorticoids via an nGRE, by FoxO1 sequestration of STAT3, by NF-κB p50 binding, and by promoter DNA methylation modulated by MeCP2 [PMID:2698828, PMID:27935805, PMID:19036902, PMID:25510553, PMID:24078059, PMID:33462216]. Loss-of-function POMC mutations in humans cause early-onset obesity, adrenal insufficiency, and red hair pigmentation, confirming POMC as a monogenic determinant of energy balance, adrenal function, and pigmentation [PMID:9620771]."},"prefetch_data":{"uniprot":{"accession":"P01189","full_name":"Pro-opiomelanocortin","aliases":["Corticotropin-lipotropin"],"length_aa":267,"mass_kda":29.4,"function":"Precursor protein of pituitary hormones that are involved in diverse physiological processes, including the regulation of energy balance, stress response, immune function and skin pigmentation Functions as a ligand for the melanocortin receptors MC1R, MC2R, MC3R and MC5R (PubMed:8396929, PubMed:8463333, PubMed:8636348). Activation of MC1R increases melanogenesis in melanocytes found in the skin and hair (PubMed:9620771). Binding to MC2R stimulates the adrenal glands to secrete cortisol (PubMed:8636348). Contributes to the regulation of energy homeostasis through activation of MC3R (Probable). Involved in the regulation exocrine gland function through MC5R activation (By similarity) Serves as a ligand for the melanocortin receptors MC1R, MC3R, MC4R and MC5R (PubMed:8392067, PubMed:8396929, PubMed:8463333). Activation of MC1R promotes melanogenesis in melanocytes of the skin and hair (PubMed:10403794, PubMed:9620771). Contributes to the regulation of energy homeostasis through activation of MC3R (Probable). Through MC4R activation, functions as an anorexigenic peptide (PubMed:8392067). Promotes immunosuppression and involved in the regulation exocrine gland function through MC5R activation (By similarity) Functions as a ligand for the melanocortin receptors MC1R, MC3R, MC4R and MC5R (PubMed:8396929, PubMed:8463333). Activation of MC1R increases melanogenesis in melanocytes found in the skin and hair (Probable). Contributes to the regulation of energy homeostasis through activation of MC3R (Probable). Through MC4R activation, functions as an anorexigenic peptide (PubMed:8392067). Involved in the regulation exocrine gland function through MC5R activation (By similarity) Functions as a ligand for the melanocortin receptors MC1R, MC3R, MC4R and MC5R (PubMed:8396929, PubMed:8463333). Activation of MC1R increases melanogenesis in melanocytes found in the skin and hair (Probable). Contributes to the regulation of energy homeostasis through activation of MC3R (Probable). Binds to MC4R with low potency (PubMed:8392067). Involved in the regulation exocrine gland function through MC5R activation (By similarity) Endogenous orexigenic opiate Endogenous opiate","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P01189/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POMC","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/POMC","total_profiled":1310},"omim":[{"mim_id":"617869","title":"NK1 HOMEOBOX 1; NKX1-1","url":"https://www.omim.org/entry/617869"},{"mim_id":"616914","title":"MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME; MFLS","url":"https://www.omim.org/entry/616914"},{"mim_id":"615410","title":"MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN 2; MRAP2","url":"https://www.omim.org/entry/615410"},{"mim_id":"614785","title":"MITOCHONDRIAL FISSION FACTOR; MFF","url":"https://www.omim.org/entry/614785"},{"mim_id":"613886","title":"OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD","url":"https://www.omim.org/entry/613886"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"pituitary gland","ntpm":30726.6}],"url":"https://www.proteinatlas.org/search/POMC"},"hgnc":{"alias_symbol":["MSH","POC","CLIP","ACTH","NPP","LPH"],"prev_symbol":[]},"alphafold":{"accession":"P01189","domains":[{"cath_id":"-","chopping":"10-55","consensus_level":"medium","plddt":74.5322,"start":10,"end":55}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P01189","model_url":"https://alphafold.ebi.ac.uk/files/AF-P01189-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P01189-F1-predicted_aligned_error_v6.png","plddt_mean":57.66},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POMC","jax_strain_url":"https://www.jax.org/strain/search?query=POMC"},"sequence":{"accession":"P01189","fasta_url":"https://rest.uniprot.org/uniprotkb/P01189.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P01189/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P01189"}},"corpus_meta":[{"pmid":"8781560","id":"PMC_8781560","title":"Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B.","date":"1996","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8781560","citation_count":284,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17764572","id":"PMC_17764572","title":"The role of proopiomelanocortin (POMC) neurones in feeding behaviour.","date":"2007","source":"Nutrition & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17764572","citation_count":238,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27869800","id":"PMC_27869800","title":"A rapidly acting glutamatergic ARC→PVH satiety circuit postsynaptically regulated by α-MSH.","date":"2016","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27869800","citation_count":213,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3025825","id":"PMC_3025825","title":"ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists.","date":"1986","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/3025825","citation_count":202,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19770186","id":"PMC_19770186","title":"Hormone and glucose signalling in POMC and AgRP neurons.","date":"2009","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19770186","citation_count":195,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20160350","id":"PMC_20160350","title":"PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice.","date":"2010","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/20160350","citation_count":169,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16936203","id":"PMC_16936203","title":"Heterozygosity for a POMC-null mutation and increased obesity risk in humans.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16936203","citation_count":157,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12498389","id":"PMC_12498389","title":"Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells.","date":"2002","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/12498389","citation_count":149,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27797762","id":"PMC_27797762","title":"CLIP Tool Kit (CTK): a flexible and robust pipeline to analyze CLIP sequencing data.","date":"2017","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27797762","citation_count":142,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34002087","id":"PMC_34002087","title":"Functionally distinct POMC-expressing neuron subpopulations in hypothalamus revealed by intersectional targeting.","date":"2021","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34002087","citation_count":130,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2829991","id":"PMC_2829991","title":"Pro-opiomelanocortin-derived peptides (ACTH/beta-endorphin/alpha-MSH) in brainstem baroreceptor areas of the rat.","date":"1987","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/2829991","citation_count":127,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15833364","id":"PMC_15833364","title":"CRH stimulates POMC activity and corticosterone production in dermal fibroblasts.","date":"2005","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/15833364","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10652501","id":"PMC_10652501","title":"Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome.","date":"2000","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/10652501","citation_count":110,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22166984","id":"PMC_22166984","title":"Defining POMC neurons using transgenic reagents: impact of transient Pomc expression in diverse immature neuronal populations.","date":"2011","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/22166984","citation_count":107,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18234336","id":"PMC_18234336","title":"Effects of non-human species irradiation after the Chernobyl NPP accident.","date":"2008","source":"Environment international","url":"https://pubmed.ncbi.nlm.nih.gov/18234336","citation_count":101,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30230471","id":"PMC_30230471","title":"Insulin regulates POMC neuronal plasticity to control glucose metabolism.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30230471","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28489068","id":"PMC_28489068","title":"TNFα drives mitochondrial stress in POMC neurons in obesity.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28489068","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16681590","id":"PMC_16681590","title":"Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors.","date":"2006","source":"Clinical and experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/16681590","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9571181","id":"PMC_9571181","title":"Human pigmentation phenotype: a point mutation generates nonfunctional MSH receptor.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9571181","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24506071","id":"PMC_24506071","title":"Early-life stress reduces DNA methylation of the Pomc gene in male mice.","date":"2014","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24506071","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21388402","id":"PMC_21388402","title":"Evolution of POMC: origin, phylogeny, posttranslational processing, and the melanocortins.","date":"2011","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21388402","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12376393","id":"PMC_12376393","title":"Hypothalamic NPY, AGRP, and POMC mRNA responses to leptin and refeeding in mice.","date":"2002","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12376393","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11511529","id":"PMC_11511529","title":"In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin.","date":"2001","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/11511529","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9877097","id":"PMC_9877097","title":"Does alpha-MSH have a role in regulating skin pigmentation in humans?","date":"1998","source":"Pigment cell research","url":"https://pubmed.ncbi.nlm.nih.gov/9877097","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2552843","id":"PMC_2552843","title":"ACTH-(4-10) through gamma-MSH: evidence for a new class of central autonomic nervous system-regulating peptides.","date":"1989","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2552843","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8137518","id":"PMC_8137518","title":"ACTH precursors characterize the ectopic ACTH syndrome.","date":"1994","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8137518","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28099839","id":"PMC_28099839","title":"TrpC5 Mediates Acute Leptin and Serotonin Effects via Pomc Neurons.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28099839","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24205303","id":"PMC_24205303","title":"SNAP-, CLIP- and Halo-tag labelling of budding yeast cells.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24205303","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2836169","id":"PMC_2836169","title":"Immunoreactive proopiomelanocortin (POMC) peptides and POMC-like messenger ribonucleic acid are present in many rat nonpituitary tissues.","date":"1988","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/2836169","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22245570","id":"PMC_22245570","title":"AgRP and POMC neurons are hypophysiotropic and coordinately regulate multiple endocrine axes in a larval teleost.","date":"2012","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22245570","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28190775","id":"PMC_28190775","title":"DRP1 Suppresses Leptin and Glucose Sensing of POMC Neurons.","date":"2017","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28190775","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11268349","id":"PMC_11268349","title":"The role of alpha-MSH as a modulator of cutaneous inflammation.","date":"2000","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/11268349","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24451213","id":"PMC_24451213","title":"PIPE-CLIP: a comprehensive online tool for CLIP-seq data analysis.","date":"2014","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/24451213","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30833113","id":"PMC_30833113","title":"Chronic Low-grade Inflammatory Phenotype (CLIP) and Senescent Immune Dysregulation.","date":"2019","source":"Clinical therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/30833113","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25855171","id":"PMC_25855171","title":"Fertility-regulating Kiss1 neurons arise from hypothalamic POMC-expressing progenitors.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25855171","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7855066","id":"PMC_7855066","title":"Cultured human melanocytes respond to MSH peptides and ACTH.","date":"1994","source":"Pigment cell research","url":"https://pubmed.ncbi.nlm.nih.gov/7855066","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26793988","id":"PMC_26793988","title":"60 YEARS OF POMC: Adrenal and extra-adrenal functions of ACTH.","date":"2016","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26793988","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25634597","id":"PMC_25634597","title":"Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25634597","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10816655","id":"PMC_10816655","title":"alpha-MSH and the regulation of melanocyte function.","date":"1999","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10816655","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20191296","id":"PMC_20191296","title":"DNA methylation of the POMC gene promoter is associated with craving in alcohol dependence.","date":"2010","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/20191296","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10799663","id":"PMC_10799663","title":"ARC POMC mRNA and PVN alpha-MSH are lower in obese relative to lean zucker rats.","date":"2000","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10799663","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10816644","id":"PMC_10816644","title":"UV light and MSH receptors.","date":"1999","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10816644","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12768537","id":"PMC_12768537","title":"Adrenocortical zonation and ACTH.","date":"2003","source":"Microscopy research and technique","url":"https://pubmed.ncbi.nlm.nih.gov/12768537","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15680952","id":"PMC_15680952","title":"Effects of fasting, leptin, and insulin on AGRP and POMC peptide release in the hypothalamus.","date":"2005","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15680952","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21331413","id":"PMC_21331413","title":"Integrated systems for rapid point of care (PoC) blood cell analysis.","date":"2011","source":"Lab on a chip","url":"https://pubmed.ncbi.nlm.nih.gov/21331413","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17156199","id":"PMC_17156199","title":"Hypothalamic proopiomelanocortin (POMC) neurons have a cholinergic phenotype.","date":"2006","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17156199","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10395956","id":"PMC_10395956","title":"Molecular cloning and characterization of the chicken pro-opiomelanocortin (POMC) gene.","date":"1999","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/10395956","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18948970","id":"PMC_18948970","title":"Dietary resistant starch increases hypothalamic POMC expression in rats.","date":"2008","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/18948970","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25872650","id":"PMC_25872650","title":"Pro-Opiomelanocortin (POMC) Neurones, POMC-Derived Peptides, Melanocortin Receptors and Obesity: How Understanding of this System has Changed Over the Last Decade.","date":"2015","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25872650","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10698592","id":"PMC_10698592","title":"ACTH resistance syndromes.","date":"1999","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/10698592","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9390008","id":"PMC_9390008","title":"The melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of alpha-MSH.","date":"1997","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9390008","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16271481","id":"PMC_16271481","title":"Inherited ACTH insensitivity illuminates the mechanisms of ACTH action.","date":"2005","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/16271481","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22249810","id":"PMC_22249810","title":"The neuroendocrine circuitry controlled by POMC, MSH, and AGRP.","date":"2012","source":"Handbook of experimental pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22249810","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24078059","id":"PMC_24078059","title":"Leptin resistance and obesity in mice with deletion of methyl-CpG-binding protein 2 (MeCP2) in hypothalamic pro-opiomelanocortin (POMC) neurons.","date":"2014","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/24078059","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30068528","id":"PMC_30068528","title":"The Future of Cross-Linking and Immunoprecipitation (CLIP).","date":"2018","source":"Cold Spring Harbor perspectives in biology","url":"https://pubmed.ncbi.nlm.nih.gov/30068528","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3004731","id":"PMC_3004731","title":"Differential subcellular localization of ACTH and alpha-MSH in corticotropes of the rat anterior pituitary.","date":"1986","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/3004731","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15240582","id":"PMC_15240582","title":"Characterization of an adrenocorticotropin (ACTH) receptor promoter polymorphism leading to decreased adrenal responsiveness to ACTH.","date":"2004","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15240582","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18697863","id":"PMC_18697863","title":"Mutations in the amino-terminal region of proopiomelanocortin (POMC) in patients with early-onset obesity impair POMC sorting to the regulated secretory pathway.","date":"2008","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18697863","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23368412","id":"PMC_23368412","title":"A computational approach for identifying microRNA-target interactions using high-throughput CLIP and PAR-CLIP sequencing.","date":"2013","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/23368412","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2698828","id":"PMC_2698828","title":"Tissue-specific activity of the pro-opiomelanocortin (POMC) gene and repression by glucocorticoids.","date":"1989","source":"Genome","url":"https://pubmed.ncbi.nlm.nih.gov/2698828","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28028078","id":"PMC_28028078","title":"Ire1α in Pomc Neurons Is Required for Thermogenesis and Glycemia.","date":"2016","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/28028078","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19146848","id":"PMC_19146848","title":"Early embryonic requirement for nucleoporin Nup35/NPP-19 in nuclear assembly.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19146848","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15845926","id":"PMC_15845926","title":"Hypomethylation in the promoter region of POMC gene correlates with ectopic overexpression in thymic carcinoids.","date":"2005","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15845926","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34644574","id":"PMC_34644574","title":"Functional heterogeneity of POMC neurons relies on mTORC1 signaling.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34644574","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8750747","id":"PMC_8750747","title":"Cardiovascular effects of gamma-MSH/ACTH-like peptides: structure-activity relationship.","date":"1995","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8750747","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17623013","id":"PMC_17623013","title":"Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential?","date":"2007","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/17623013","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15771429","id":"PMC_15771429","title":"Novel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues.","date":"2005","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15771429","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34737351","id":"PMC_34737351","title":"Lactate activates hypothalamic POMC neurons by intercellular signaling.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34737351","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27500489","id":"PMC_27500489","title":"Disruption of Gpr45 causes reduced hypothalamic POMC expression and obesity.","date":"2016","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/27500489","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"4359333","id":"PMC_4359333","title":"ACTH antagonists.","date":"1974","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/4359333","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23321476","id":"PMC_23321476","title":"Mechanisms by which the orexigen NPY regulates anorexigenic α-MSH and TRH.","date":"2013","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23321476","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11268348","id":"PMC_11268348","title":"The neuropeptide alpha-MSH in host defense.","date":"2000","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/11268348","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25013995","id":"PMC_25013995","title":"Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome.","date":"2014","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25013995","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16274846","id":"PMC_16274846","title":"Circumventing central leptin resistance: lessons from central leptin and POMC gene delivery.","date":"2005","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/16274846","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30390283","id":"PMC_30390283","title":"POMC Neurons: Feeding, Energy Metabolism, and Beyond.","date":"2018","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/30390283","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27547198","id":"PMC_27547198","title":"ACTH Antagonists.","date":"2016","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27547198","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27935805","id":"PMC_27935805","title":"E2F1-mediated human POMC expression in ectopic Cushing's syndrome.","date":"2016","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27935805","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24777477","id":"PMC_24777477","title":"CLIP-170 recruits PLK1 to kinetochores during early mitosis for chromosome alignment.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24777477","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29709556","id":"PMC_29709556","title":"GoldCLIP: Gel-omitted Ligation-dependent CLIP.","date":"2018","source":"Genomics, proteomics & bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/29709556","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10885325","id":"PMC_10885325","title":"Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity.","date":"2000","source":"Nutrition reviews","url":"https://pubmed.ncbi.nlm.nih.gov/10885325","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25510553","id":"PMC_25510553","title":"FoxO1 negatively regulates leptin-induced POMC transcription through its direct interaction with STAT3.","date":"2015","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/25510553","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34356205","id":"PMC_34356205","title":"COVID-19 Biomarkers and Advanced Sensing Technologies for Point-of-Care (POC) Diagnosis.","date":"2021","source":"Bioengineering (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34356205","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26671895","id":"PMC_26671895","title":"60 YEARS OF POMC: POMC: an evolutionary perspective.","date":"2015","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26671895","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32233503","id":"PMC_32233503","title":"Detection and Quantification of HspX Antigen in Sputum Samples Using Plasmonic Biosensing: Toward a Real Point-of-Care (POC) for Tuberculosis Diagnosis.","date":"2020","source":"ACS infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/32233503","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8383343","id":"PMC_8383343","title":"An ACTH/MSH(4-9) analog counteracts the behavioral effects of a mineralocorticoid receptor antagonist.","date":"1993","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/8383343","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6310240","id":"PMC_6310240","title":"Multiple factors involved in the control of ACTH and alpha-MSH secretion.","date":"1983","source":"Journal of steroid biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6310240","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8734450","id":"PMC_8734450","title":"The ACTH receptor.","date":"1996","source":"Bailliere's clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/8734450","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25782002","id":"PMC_25782002","title":"Apelin-13 enhances arcuate POMC neuron activity via inhibiting M-current.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25782002","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10218968","id":"PMC_10218968","title":"Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.","date":"1999","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10218968","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33462216","id":"PMC_33462216","title":"Loss of POMC-mediated antinociception contributes to painful diabetic neuropathy.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33462216","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33250721","id":"PMC_33250721","title":"Activation of the ARCPOMC→MeA Projection Reduces Food Intake.","date":"2020","source":"Frontiers in neural circuits","url":"https://pubmed.ncbi.nlm.nih.gov/33250721","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1680721","id":"PMC_1680721","title":"ACTH/MSH-like peptides inhibit the binding of dopaminergic ligands to the dopamine D2 receptor in vitro.","date":"1991","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1680721","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28350524","id":"PMC_28350524","title":"An ATF4-ATG5 signaling in hypothalamic POMC neurons regulates obesity.","date":"2017","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/28350524","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34395386","id":"PMC_34395386","title":"The Impact of Recent Developments in Electrochemical POC Sensor for Blood Sugar Care.","date":"2021","source":"Frontiers in chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34395386","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12851298","id":"PMC_12851298","title":"alpha-MSH and desacetyl-alpha-MSH signaling through melanocortin receptors.","date":"2003","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/12851298","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26643913","id":"PMC_26643913","title":"60 YEARS OF POMC: The proopiomelanocortin gene: discovery, deletion and disease.","date":"2015","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26643913","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24178558","id":"PMC_24178558","title":"HITS-CLIP (CLIP-Seq) for mouse Piwi proteins.","date":"2014","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/24178558","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17028769","id":"PMC_17028769","title":"Antimicrobial properties of alpha-MSH and related synthetic melanocortins.","date":"2006","source":"TheScientificWorldJournal","url":"https://pubmed.ncbi.nlm.nih.gov/17028769","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19036902","id":"PMC_19036902","title":"Liver X receptor-alpha regulates proopiomelanocortin (POMC) gene transcription in the pituitary.","date":"2008","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19036902","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24940765","id":"PMC_24940765","title":"HITS-CLIP and PAR-CLIP advance viral miRNA targetome analysis.","date":"2014","source":"Critical reviews in eukaryotic gene expression","url":"https://pubmed.ncbi.nlm.nih.gov/24940765","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20935630","id":"PMC_20935630","title":"Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20935630","citation_count":2251,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1325670","id":"PMC_1325670","title":"The cloning of a family of genes that encode the melanocortin receptors.","date":"1992","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/1325670","citation_count":1443,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9620771","id":"PMC_9620771","title":"Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans.","date":"1998","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9620771","citation_count":1244,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8392067","id":"PMC_8392067","title":"Molecular cloning, expression, and gene localization of a fourth melanocortin receptor.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8392067","citation_count":734,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7566098","id":"PMC_7566098","title":"Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7566098","citation_count":660,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8463333","id":"PMC_8463333","title":"Molecular cloning of a novel melanocortin receptor.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8463333","citation_count":605,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18391951","id":"PMC_18391951","title":"Many sequence variants affecting diversity of adult human height.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18391951","citation_count":520,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8208289","id":"PMC_8208289","title":"Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein.","date":"1994","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8208289","citation_count":517,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7477400","id":"PMC_7477400","title":"The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7477400","citation_count":505,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23563607","id":"PMC_23563607","title":"Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23563607","citation_count":496,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28319085","id":"PMC_28319085","title":"Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.","date":"2017","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28319085","citation_count":378,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23426689","id":"PMC_23426689","title":"Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23426689","citation_count":366,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17122358","id":"PMC_17122358","title":"Genetics of obesity in humans.","date":"2006","source":"Endocrine reviews","url":"https://pubmed.ncbi.nlm.nih.gov/17122358","citation_count":341,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"6196780","id":"PMC_6196780","title":"High-resolution chromosomal localization of human genes for amylase, proopiomelanocortin, somatostatin, and a DNA fragment (D3S1) by in situ hybridization.","date":"1983","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/6196780","citation_count":336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17079660","id":"PMC_17079660","title":"Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats.","date":"2006","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17079660","citation_count":328,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8396929","id":"PMC_8396929","title":"Molecular cloning of a novel human melanocortin receptor.","date":"1993","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8396929","citation_count":299,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8185570","id":"PMC_8185570","title":"Molecular cloning, expression, and characterization of a fifth melanocortin receptor.","date":"1994","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8185570","citation_count":277,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12697721","id":"PMC_12697721","title":"Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin.","date":"2003","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12697721","citation_count":270,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7905839","id":"PMC_7905839","title":"Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment.","date":"1994","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7905839","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21980299","id":"PMC_21980299","title":"A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21980299","citation_count":260,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16876134","id":"PMC_16876134","title":"Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats.","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16876134","citation_count":243,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10403794","id":"PMC_10403794","title":"Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10403794","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12165561","id":"PMC_12165561","title":"A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism.","date":"2002","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12165561","citation_count":193,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"6254047","id":"PMC_6254047","title":"Structural organization of human genomic DNA encoding the pro-opiomelanocortin peptide.","date":"1980","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/6254047","citation_count":184,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44504,"output_tokens":7243,"usd":0.121079},"stage2":{"model":"claude-opus-4-6","input_tokens":10926,"output_tokens":4459,"usd":0.249158},"total_usd":0.842993,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":56081,"output_tokens":13360,"usd":0.184321},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":18118,"output_tokens":4068,"usd":0.288435}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"Tissue-specific expression of the POMC gene in pituitary corticotropes and melanotropes is controlled by regulatory DNA sequences within a 543-bp fragment in the 5'-flanking region. A negative glucocorticoid response element (nGRE) in the proximal POMC promoter mediates glucocorticoid repression, and this element also binds COUP family transcription factors, suggesting mutually exclusive binding of the glucocorticoid receptor and COUP factors as the mechanism of repression.\",\n      \"method\": \"DNA-mediated gene transfer into transgenic mice and tissue culture cells; identification of nuclear protein binding sites by EMSA\",\n      \"journal\": \"Genome\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vivo transgenic and in vitro transfection assays with defined promoter elements and mutagenesis\",\n      \"pmids\": [\"2698828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"ACTH and alpha-MSH are differentially sorted into distinct secretory granule populations in rat anterior pituitary corticotropes, indicating post-translational segregation of POMC-derived peptides at the subcellular level.\",\n      \"method\": \"Double-labeling immunoelectron microscopy (ferritin for alpha-MSH, colloidal gold for ACTH) in rat anterior pituitary\",\n      \"journal\": \"Cell and tissue research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct subcellular localization experiment with dual-label EM, single study\",\n      \"pmids\": [\"3004731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"POMC gene is expressed in many rat non-pituitary tissues (testis, duodenum, kidney, colon, liver, lung, stomach) producing a shorter (~800 nt) POMC-like mRNA, and immunoreactive ACTH, beta-endorphin, and gamma-MSH were detected, indicating tissue-specific and extra-pituitary POMC expression and processing.\",\n      \"method\": \"Northern blot hybridization with exon 3 riboprobe; radioimmunoassay; gel filtration chromatography of tissue extracts\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (Northern blot, RIA, gel filtration) across multiple tissues\",\n      \"pmids\": [\"2836169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"UVB radiation stimulates POMC gene expression and production/release of alpha-MSH and ACTH by human melanocytes and keratinocytes; this effect is also stimulated by cAMP (dbcAMP) and IL-1alpha, and is abolished by the free-radical scavenger N-acetyl-cysteine, implicating a cAMP-dependent, oxidative stress-responsive pathway.\",\n      \"method\": \"Cell culture with UVB irradiation; peptide secretion assay (RIA); pharmacological manipulation (dbcAMP, IL-1alpha, NAC)\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple conditions tested with RIA readout, replicated across cell types\",\n      \"pmids\": [\"8781560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CRH stimulates POMC gene expression, ACTH production/release, and subsequent corticosterone production in human dermal fibroblasts (but not keratinocytes) via a cAMP-dependent pathway, establishing a functional local CRH-POMC-corticosteroid axis in skin fibroblasts analogous to the HPA axis.\",\n      \"method\": \"Cell culture; cAMP assay; POMC mRNA and protein measurement; ACTH and corticosterone ELISA in fibroblasts vs. keratinocytes\",\n      \"journal\": \"Journal of neuroimmunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple readouts (cAMP, mRNA, peptide, steroid) in defined cell types, single lab\",\n      \"pmids\": [\"15833364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Naturally occurring missense mutations in the N-terminal region of POMC (C28F and L37F) found in obese patients impair sorting of POMC to the regulated secretory pathway, redirecting it to the constitutive secretory pathway, thereby reducing proteolytic processing to bioactive peptides without reducing intracellular POMC levels.\",\n      \"method\": \"Metabolic labeling, Western blotting, immunoassay of lysates and conditioned media from transiently transfected beta-TC3 cells\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal biochemical methods establishing a novel trafficking mechanism, human mutations studied\",\n      \"pmids\": [\"18697863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DNA methylation of the Pomc promoter represses Pomc transcription; methyl-CpG-binding protein-2 (MeCP2) binds the distal Pomc promoter and acts with HDAC2 and DNMT1 to repress expression. Early-life stress reduces Pomc promoter methylation and increases pituitary Pomc mRNA. Loss of MeCP2 in POMC neurons increases DNA methylation at the Pomc promoter and reduces POMC expression, causing obesity and leptin resistance.\",\n      \"method\": \"Bisulfite sequencing; EMSA (MeCP2 binding); luciferase promoter assays; conditional KO mouse (Mecp2flox/y/Pomc-Cre); metabolic phenotyping\",\n      \"journal\": \"Endocrinology / Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including in vivo KO, bisulfite sequencing, and in vitro promoter assays; replicated across two papers\",\n      \"pmids\": [\"24506071\", \"24078059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Hypomethylation of a critical region (-417 to -260 bp) in the POMC promoter, spanning the E2F transcription factor binding region, correlates with ectopic POMC overexpression in thymic carcinoids causing ectopic ACTH syndrome, while normal thymus shows hypermethylation of this region.\",\n      \"method\": \"Bisulfite sequencing of POMC promoter CpG island in tumor vs. normal tissue; correlation of methylation density with POMC expression levels\",\n      \"journal\": \"The Journal of endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — bisulfite sequencing with expression correlation, single study in human tissue\",\n      \"pmids\": [\"15845926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"E2F1 drives ectopic POMC transcription in non-pituitary tumor cells independently of the pituitary-specific Tpit/Pitx1 mechanism. E2F1 binds the proximal hPOMC promoter (-42 to +68) with DNA-binding activity controlled by phosphorylation at Ser-337. Co-expression of E2F1 and its heterodimer partner DP1 upregulates hPOMC mRNA up to 40-fold. E2F1 inhibitors suppressed hPOMC expression and ACTH in ectopic Cushing's cell lines and xenografted mice.\",\n      \"method\": \"Promoter-reporter assays; ChIP; co-expression of E2F1/DP1; pharmacological E2F1 inhibition; in vivo xenograft model\",\n      \"journal\": \"Endocrine-related cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple methods (reporter assay, ChIP, mutagenesis, in vivo validation) in single rigorous study\",\n      \"pmids\": [\"27935805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Liver X receptor-alpha (LXR-alpha) positively regulates POMC gene transcription in the pituitary. The RXR-alpha/LXR-alpha heterodimer binds to the POMC promoter region between -73 and -52 bp; LXR agonist treatment increases POMC mRNA, ACTH tissue content, and plasma ACTH/corticosterone. LXR-alpha silencing abolishes LXR-ligand-induced POMC promoter activity.\",\n      \"method\": \"LXR agonist treatment in vivo and in vitro; siRNA knockdown; EMSA; ChIP; promoter-reporter assays in GH3 and AtT-20 cells\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — EMSA, ChIP, siRNA, and reporter assays with in vivo corroboration in single study\",\n      \"pmids\": [\"19036902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FoxO1 inhibits leptin-induced POMC transcription by two mechanisms: (1) direct binding to the POMC promoter, and (2) direct interaction with STAT3 via residues Gly140-Leu160 (key residues Gln145, Arg147, Lys148, Arg153, Arg154), preventing STAT3 from binding the SP1-POMC promoter complex. FoxO3 (but not FoxO4) similarly interacts with STAT3 and inhibits POMC promoter activity.\",\n      \"method\": \"Co-immunoprecipitation; deletion/point mutagenesis; luciferase reporter assay; computational docking simulation\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis + co-IP + reporter assay identifying specific interaction residues, single lab\",\n      \"pmids\": [\"25510553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance: POMC neuron-specific PTP1B deletion improves leptin sensitivity and energy expenditure, while POMC neuron-specific SHP2 deletion reduces leptin sensitivity and markedly reduces hypothalamic POMC mRNA and alpha-MSH peptide levels, revealing SHP2 as a novel positive regulator of melanocortin system function.\",\n      \"method\": \"Conditional KO mice (Cre-lox); metabolic phenotyping; hyperinsulinemic-euglycemic clamp; hypothalamic POMC mRNA and peptide measurement\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional neuron-specific KO with multiple physiological readouts and peptide quantification\",\n      \"pmids\": [\"20160350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NPY inhibits the posttranslational processing of POMC to active alpha-MSH by decreasing prohormone convertase-2 (PC2) expression via NPY-Y1 receptor signaling and the transcription factor Egr-1. NPY also reduces alpha-MSH levels in the PVN and attenuates alpha-MSH-induced CREB phosphorylation, thus decreasing TRH production.\",\n      \"method\": \"Pharmacological NPY administration; Y1 receptor antagonism; Egr-1 analysis; PC2 mRNA and protein measurement; in vitro and in vivo studies in rat hypothalamus\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vivo and in vitro readouts establishing NPY→Y1R→Egr-1→PC2→POMC processing pathway, single lab\",\n      \"pmids\": [\"23321476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GPR45 (an orphan GPCR) regulates POMC expression in a cell-autonomous manner via the JAK/STAT pathway. Disruption of Gpr45 reduces POMC expression and energy expenditure; intraventricular administration of the alpha-MSH analog melanotan-2 rescued obesity in Gpr45 mutant mice.\",\n      \"method\": \"Insertional mutagenesis mouse screen; conditional KO; JAK/STAT pathway analysis; intraventricular peptide rescue experiment\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model with pathway identification and pharmacological rescue, single lab\",\n      \"pmids\": [\"27500489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Insulin activates a subset of POMC neurons to repress hepatic glucose production (HGP). The proportion of POMC neurons activated by insulin is regulated by the phosphatase TCPTP, which is increased by fasting and degraded after feeding. TCPTP deficiency in POMC neurons enhances insulin signaling and increases the proportion of insulin-activated POMC neurons, repressing HGP; elevated TCPTP (in obesity/fasting) reduces POMC neuron activation by insulin and impairs HGP repression.\",\n      \"method\": \"Conditional KO mice; electrophysiology; hyperinsulinemic-euglycemic clamp; hepatic glucose output measurements\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with electrophysiology, clamp studies and defined molecular mechanism (TCPTP regulation of insulin signaling in POMC neurons)\",\n      \"pmids\": [\"30230471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TrpC5 channels in POMC neurons are required for the acute anorexigenic effects of leptin and serotonin 2C receptor (Ht2Cr) agonists. POMC-specific Trpc5 deletion blunts electrophysiological responses of POMC neurons to both leptin and Ht2Cr agonists, increases food intake, decreases energy expenditure, and blocks lorcaserin-induced improvement in glucose/insulin tolerance.\",\n      \"method\": \"Conditional KO mice (Pomc-Cre); electrophysiology; food intake and energy expenditure measurements; glucose tolerance tests\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with electrophysiological and metabolic phenotypic readouts, multiple orthogonal endpoints\",\n      \"pmids\": [\"28099839\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DRP1-mediated mitochondrial fission in POMC neurons regulates leptin sensitivity and glucose sensing. Inducible DRP1 deletion in mature POMC neurons increases mitochondrial size and ROS production, improves leptin sensitivity and glucose responsiveness, and enhances Kcnj11 (Kir6.2) mRNA expression via PPAR, linking mitochondrial dynamics to POMC neuron function.\",\n      \"method\": \"Inducible conditional KO (Drp1fl/fl-POMC-cre:ERT2); electrophysiology; mitochondrial morphology imaging; glucose clamp; qPCR\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible conditional KO with multiple cellular and physiological readouts and mechanistic pathway identification\",\n      \"pmids\": [\"28190775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In diet-induced obesity, persistently activated microglia hypersecrete TNFα, which stimulates mitochondrial ATP production and fusion in POMC neuron neurites, increasing POMC neuronal excitability. Disruption of TNFSF11A or NDUFAB1 (TNFα downstream signals) in the mediobasal hypothalamus reverses mitochondrial elongation and reduces obesity.\",\n      \"method\": \"Conditional gene disruption in MBH; mitochondrial morphology imaging; electrophysiology; in vivo obesity model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic manipulation with cellular and physiological readouts, single lab\",\n      \"pmids\": [\"28489068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"IRE1alpha in POMC neurons is required for normal thermogenesis, energy expenditure, and glucose homeostasis. POMC-specific IRE1alpha deficiency causes ER stress, predisposes POMC neurons to leptin and insulin resistance, impairs thermogenic responses, and disrupts hepatic insulin sensitivity.\",\n      \"method\": \"Conditional KO mice (Pomc-Cre); energy expenditure measurement; glucose/insulin tolerance tests; ER stress markers; leptin signaling assays\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with multiple metabolic and cellular phenotypic readouts, single lab\",\n      \"pmids\": [\"28028078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ATF4 in POMC neurons regulates energy homeostasis by directly binding to the ATG5 promoter to suppress its expression. Atf4 deletion in POMC neurons upregulates ATG5 and autophagy, increasing alpha-MSH production and energy expenditure; double KO of Atf4 and Atg5 in POMC neurons reverses these effects, placing ATF4→ATG5/autophagy→alpha-MSH in a linear pathway.\",\n      \"method\": \"Conditional KO and double KO mice (POMC-Cre); promoter binding assay (ChIP); alpha-MSH measurement; energy expenditure\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with epistasis (double KO) and promoter binding data, single lab\",\n      \"pmids\": [\"28350524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Glutamatergic ARC neurons (expressing oxytocin receptor) rapidly cause satiety by projecting to MC4R-expressing PVH neurons; the POMC neuron-derived MC4R agonist alpha-MSH potentiates transmission across the ARCGlutamatergic→PVHMC4R synapse, establishing a postsynaptic modulatory role for POMC-derived alpha-MSH in the ARC→PVH satiety circuit.\",\n      \"method\": \"Chemogenetics (DREADD); optogenetics; electrophysiology; circuit tracing; peptide pharmacology\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple circuit-level methods (optogenetics, chemogenetics, electrophysiology) converging on a defined synaptic mechanism\",\n      \"pmids\": [\"27869800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"POMCLepr+ and POMCGlp1r+ neuron subpopulations in the ARC represent largely non-overlapping populations with distinct electrophysiological properties, anatomical distributions, receptor expression profiles, and differential ability to suppress feeding, demonstrating functional heterogeneity within POMC neurons.\",\n      \"method\": \"Intersectional Cre/Dre-dependent mouse models; translational profiling; electrophysiology; chemogenetics; feeding assays\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — novel intersectional genetic approach with multiple orthogonal methods identifying functionally distinct subpopulations\",\n      \"pmids\": [\"34002087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"mTORC1 activity in POMC neurons orchestrates functional heterogeneity: blockade of mTORC1 decreases alpha-MSH, recruits POMC/GABAergic neurotransmission (restrained by CB1R signaling), simultaneously activates POMC/GABAergic and inhibits POMC/glutamatergic neurons, causing hyperphagia.\",\n      \"method\": \"Conditional mutagenesis; chemogenetics; optogenetics; electrophysiology; alpha-MSH measurement\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal circuit-level and molecular methods in single rigorous study\",\n      \"pmids\": [\"34644574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In diabetic mice, the POMC promoter is repressed by increased binding of NF-kB p50 subunit, reducing POMC levels in peripheral sensory neurons. Additionally, mu-opioid receptor (MOR) undergoes lysosomal degradation in diabetes, further impairing POMC antinociception. Viral overexpression of POMC and MOR in sensory ganglia rescues the neuropathic pain phenotype.\",\n      \"method\": \"ChIP for NF-kB p50; POMC promoter analysis; lysosomal degradation assay; viral vector overexpression rescue in diabetic mice; sensory nerve tissue from diabetic patients\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP identifying transcriptional repressor, receptor degradation mechanism, and in vivo rescue experiment\",\n      \"pmids\": [\"33462216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Lactate activates hypothalamic POMC neurons via intercellular (astrocyte-to-neuron) signaling: HCAR1 (hydroxycarboxylic acid receptor 1) is expressed on astrocytes (not on POMC neurons), and lactate/HCAR1 agonist depolarizes POMC neurons through Galphai/o-protein-coupled receptor signaling. A subset of POMC neurons is also directly depolarized by intracellular lactate via lactate transporters.\",\n      \"method\": \"Conditional genetic labeling of POMC neurons; patch-clamp electrophysiology; pharmacological dissection (PTX, 4-CIN, 3Cl-HBA); HCAR1 immunolocalization\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology with pharmacological dissection and receptor localization, single lab\",\n      \"pmids\": [\"34737351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Optogenetic stimulation of ARCPOMC axonal projections to the medial amygdala (MeA) reduces short-term food intake; this effect is blocked by the MC4R antagonist SHU9119. ARC POMC neurons synapse onto estrogen receptor-alpha- and MC4R-expressing MeA neurons, identifying a novel extrahypothalamic melanocortinergic circuit for feeding regulation.\",\n      \"method\": \"Anterograde and retrograde viral tracing; double immunohistochemistry; optogenetics; pharmacological MC4R blockade\",\n      \"journal\": \"Frontiers in neural circuits\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — circuit anatomy and optogenetics with pharmacological validation, single lab\",\n      \"pmids\": [\"33250721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Apelin-13 activates APJ receptors on POMC neurons, triggering Gbeta-gamma-dependent PLC-beta signaling that inhibits M-type potassium current (carried by KCNQ2/3/5 subunits), thereby depolarizing approximately half of POMC neurons. Single-cell qPCR confirmed APJ receptor, PLC-beta isoforms, and KCNQ subunits in POMC neurons.\",\n      \"method\": \"Electrophysiology (patch-clamp); pharmacological dissection (pertussis toxin, gallein, PLC inhibitor, KCNQ inhibitor); single-cell qPCR\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology with pharmacological dissection of signaling pathway, single lab\",\n      \"pmids\": [\"25782002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1974,\n      \"finding\": \"The tryptophan residue at position 9 of ACTH is essential for stimulation of adrenal adenylate cyclase; substitution with phenylalanine or N-alpha-methyltryptophan yields ACTH analogs that retain high receptor affinity but fail to activate adenylate cyclase, demonstrating that receptor binding is insufficient for hormonal activity and identifying a key catalytic determinant.\",\n      \"method\": \"In vitro adenylate cyclase assay with bovine adrenal cortical plasma membranes; ACTH analog synthesis and structure-activity analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay with structure-activity relationship and mutagenesis establishing catalytic mechanism\",\n      \"pmids\": [\"4359333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Hypothalamic POMC neurons in the arcuate nucleus co-express markers of cholinergic neurotransmission (ChAT and VAChT) along with alpha-MSH and CART, while NPY/AgRP neurons are distinct from VAChT-immunoreactive cells, suggesting co-release of acetylcholine with POMC-derived peptides as a mechanism for energy balance regulation.\",\n      \"method\": \"Double-labeling immunohistochemistry with antisera to ChAT, VAChT, alpha-MSH, NPY, AGRP, CART in colchicine-treated rats\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct co-localization by dual immunohistochemistry, single study\",\n      \"pmids\": [\"17156199\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POMC is a precursor polypeptide processed in a tissue-specific manner by prohormone convertases to yield melanocortins (alpha-, beta-, gamma-MSH, ACTH) and beta-endorphin; in hypothalamic ARC neurons, POMC-derived alpha-MSH acts as an MC4R agonist to suppress feeding and regulate energy expenditure through projections to the PVH and MeA, with neuronal activity and peptide production controlled by leptin (via STAT3/FoxO1/SHP2/TCPTP signaling), insulin, glucose/lactate sensing, mitochondrial dynamics (DRP1/IRE1alpha/mTORC1), and transcriptional regulators (glucocorticoid receptor/nGRE, E2F1, LXR-alpha, MeCP2/DNA methylation) that govern both pituitary and hypothalamic POMC expression.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1980,\n      \"finding\": \"The human POMC genomic DNA encodes the corticotropin-β-lipotropin precursor as a single gene; nucleotide sequencing revealed pairs of basic amino acid residues (Lys-Arg) punctuating conserved segments corresponding to component peptide hormones ACTH and β-lipotropin, with no intervening sequence over the exon 3 region, establishing the structural basis for proteolytic processing.\",\n      \"method\": \"Genomic DNA isolation, electron microscope heteroduplex analysis, gel blotting, and nucleotide sequencing compared with bovine cDNA\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct sequencing of human genomic DNA with functional annotation of cleavage sites; foundational paper with 184 citations\",\n      \"pmids\": [\"6254047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"The human POMC gene was chromosomally localized to 2p23 by in situ hybridization, establishing its genomic map position.\",\n      \"method\": \"In situ hybridization to stretched prometaphase chromosomes with high-resolution banding\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct cytogenetic mapping; replicated in subsequent studies\",\n      \"pmids\": [\"6196780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"CRF stimulates ACTH secretion from anterior pituitary cells and α-MSH secretion from pars intermedia cells via adenylate cyclase activation at the pituitary level; α1-adrenergic agents stimulate ACTH directly at the pituitary, while β-adrenergic and antidopaminergic agents act suprapituitarily. Dopamine receptor activation inhibits pars intermedia activity.\",\n      \"method\": \"Primary culture of rat anterior and intermediate pituitary cells; adenylate cyclase assay; in vivo peptide measurements\",\n      \"journal\": \"Journal of steroid biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro cell-culture assay combined with in vivo validation, multiple signaling pathways tested\",\n      \"pmids\": [\"6310240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"ACTH and α-MSH peptides in the rat anterior pituitary are differentially stored in distinct secretory granule populations within corticotropes, as revealed by double-label immunocytochemistry; three subtypes of corticotropes were distinguished by their relative content of ACTH vs. α-MSH immunoreactivity.\",\n      \"method\": \"Double-labeling immunocytochemistry (ferritin for α-MSH; colloidal gold for ACTH) at the electron microscopy level\",\n      \"journal\": \"Cell and tissue research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — subcellular localization by electron-microscopic double immunolabeling with functional implication for differential secretion\",\n      \"pmids\": [\"3004731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"ACTH-(1-24) and α-MSH administered intracerebroventricularly suppress spontaneous feeding and abolish the feeding-stimulatory effect of κ-opioid receptor agonists, establishing that melanocortin peptides play an inhibitory role in a melanocortin-opioid homeostatic system with opposing, mutually-balancing effects.\",\n      \"method\": \"Intracerebroventricular injection in adult rats; behavioral measurement of food intake\",\n      \"journal\": \"Peptides\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — pharmacological behavioral study with single method, but clear pathway antagonism demonstrated\",\n      \"pmids\": [\"3025825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"POMC-derived peptides (ACTH, β-endorphin, α-MSH) in brainstem baroreceptor areas of the rat originate from both hypothalamic arcuate nucleus neurons and local NTS neurons; surgical lesion and transection experiments defined two descending pathways (medial and lateral) through which hypothalamic POMC fibers innervate vasomotor centers.\",\n      \"method\": \"Radioimmunoassay of brainstem peptides; 10 types of surgical lesions/transections in rat; immunohistochemistry\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple lesion approaches to map anatomical origins; well-controlled dissection study\",\n      \"pmids\": [\"2829991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"POMC gene is expressed in many rat non-pituitary tissues (testis, duodenum, kidney, colon, liver, lung, stomach, spleen) producing a shorter (~800 nt) POMC-like mRNA compared with the ~1000 nt pituitary POMC mRNA, and the resulting peptides are processed differently or turned over faster in peripheral tissues.\",\n      \"method\": \"Northern blot hybridization with exon 3 riboprobe; gel filtration chromatography; radioimmunoassay of ACTH, β-endorphin, γ-MSH\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Northern blot, RIA, chromatography) across multiple tissues\",\n      \"pmids\": [\"2836169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Glucocorticoid repression of POMC transcription is mediated by a negative glucocorticoid response element (nGRE) in the proximal POMC promoter that also binds COUP-family transcription factors; mutually exclusive binding of the glucocorticoid receptor and COUP factors to the nGRE determines cell-specific expression and glucocorticoid repression.\",\n      \"method\": \"DNA-mediated gene transfer into transgenic mice and tissue culture cells; DNA-protein binding assays\",\n      \"journal\": \"Genome\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — promoter deletion analysis in vivo (transgenic mice) and in vitro, DNA-binding assays identifying specific regulatory element\",\n      \"pmids\": [\"2698828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Peripheral γ-MSH peptides (derived from the N-terminal region of POMC) exert pressor, cardioaccelerator, and natriuretic effects dependent on central sympathetic drive and central vasopressinergic pathways; structure-activity studies identified the His-Phe-Arg-Trp core (γ-MSH-(5-8)/ACTH-(6-9)) as the minimal cardiovascular active sequence.\",\n      \"method\": \"Intravenous infusion with adrenergic/central lesion pharmacology in rats; structure-activity relationship with peptide fragments; intracarotid vs. intrajugular comparison\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological structure-activity analysis with multiple peptide fragments and lesion studies\",\n      \"pmids\": [\"2552843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"ACTH-(1-24) competes with dopamine D2 receptor agonist [3H]NPA binding in rat striatal membranes in an apparent competitive manner (increased Kd, unchanged Bmax), and structure-activity analysis showed chain length is a key determinant of this interaction; ACTH peptides also inhibit D2 antagonist binding in pituitary, septum, and substantia nigra.\",\n      \"method\": \"Radioligand binding assays with rat striatal membranes; Scatchard analysis; structure-activity with multiple ACTH fragments\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro binding assay with Scatchard analysis and structure-activity series\",\n      \"pmids\": [\"1680721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The murine and human melanocyte-stimulating hormone receptors (MC1R) and human ACTH receptor (MC2R) were cloned and identified as G-protein-coupled receptors; functional expression confirmed coupling to guanine nucleotide-binding proteins and defined the melanocortin receptor (MCR) subfamily.\",\n      \"method\": \"Molecular cloning, heterologous expression in cell lines, receptor binding assays\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — gene cloning with functional receptor characterization; >1400 citations, foundational receptor identification\",\n      \"pmids\": [\"1325670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"A fourth human melanocortin receptor (MC4R), expressed primarily in the brain (absent from adrenal cortex, melanocytes, and placenta), was cloned and shown to increase intracellular cAMP upon agonist stimulation; its pharmacological profile distinguishes it from previously described MCRs.\",\n      \"method\": \"Molecular cloning, Northern blot, in situ hybridization, transient and stable transfection in COS-1 and L-cells, cAMP assay, fluorescent in situ hybridization (chromosome 18q21.3)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — gene cloning plus functional cAMP assay plus chromosomal localization; replicated by multiple groups\",\n      \"pmids\": [\"8392067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"A third human melanocortin receptor (MC3R) was cloned; pharmacological characterization showed it responds to the heptapeptide core common to ACTH and α-, β-, and γ-MSH with increased intracellular cAMP; expression is in brain, placenta, and gut but not melanoma cells or adrenal gland.\",\n      \"method\": \"PCR-based cloning, pharmacological characterization (receptor binding and cAMP assay), Northern blot and PCR expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — gene cloning with functional receptor assay; foundational study\",\n      \"pmids\": [\"8463333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"A novel human melanocortin receptor (MC2, later also designated MC-2) was cloned; when expressed in COS-7 cells it bound [125I]-NDP-MSH and was displaced by α-, β-, γ-MSH and ACTH but not β-endorphin, with highest affinity for NDP-MSH (Ki ~5 nM); receptor is expressed in brain.\",\n      \"method\": \"Genomic cloning, COS-7 cell expression, radioligand binding displacement assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — gene cloning with functional binding characterization\",\n      \"pmids\": [\"8396929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The mouse MC5 receptor (mMC5R) was cloned and shown to couple to adenylyl cyclase (cAMP increase) upon melanocortin stimulation; potency hierarchy was α-MSH > β-MSH > ACTH > γ-MSH; N- and C-terminal portions of α-MSH, but not the core heptapeptide alone, are key for MC5R activation.\",\n      \"method\": \"PCR-based cloning, cAMP assay in transfected cells, structure-activity analysis, Northern blot\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — receptor cloning with functional cAMP assay and structure-activity dissection\",\n      \"pmids\": [\"8185570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Structural modifications at Trp9 of ACTH (substitution with Phe or N-α-methyltryptophan) produce antagonists that bind the ACTH receptor with high affinity but fail to activate the adrenal cortical adenylate cyclase system, demonstrating that Trp9 is essential for receptor activation but not binding, and that receptor occupancy alone is insufficient for hormonal activity.\",\n      \"method\": \"In vitro adenylate cyclase assay with bovine adrenal cortical plasma membranes; structure-activity analysis with ACTH analogs\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay with active-site mutagenesis equivalents (synthetic analogs), clearly dissociates binding from activation\",\n      \"pmids\": [\"4359333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"UVB radiation stimulates increased POMC gene expression accompanied by production and release of α-MSH and ACTH by normal and malignant human melanocytes and keratinocytes; this response is also stimulated by dbcAMP and IL-1α, and can be abolished by the free radical scavenger NAC, implicating a cyclic AMP-dependent pathway and oxidative stress in UVB-induced POMC peptide production.\",\n      \"method\": \"Cell culture of human melanocytes and keratinocytes; UVB irradiation; RIA for α-MSH and ACTH; pharmacological manipulation (dbcAMP, IL-1α, NAC)\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional cell-culture assay with multiple stimuli and pharmacological blockade\",\n      \"pmids\": [\"8781560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"None of the melanocortin receptors MC1, MC3, MC4, or MC5 possess binding epitopes for ACTH beyond the α-MSH sequence; MC3R shows >10-fold higher affinity for ACTH peptides than MC4R and favors the desacetylated N-terminus, suggesting MC3R as the likely mediator of short-loop negative feedback by ACTH/MSH peptides on CRF release.\",\n      \"method\": \"Competitive radioligand binding assay on transiently transfected eukaryotic cells expressing individual MCRs, using 125I-[Nle4,D-Phe7]α-MSH\",\n      \"journal\": \"The Journal of endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic binding assay across all four MCR subtypes with multiple ACTH fragment analogs\",\n      \"pmids\": [\"9390008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Two human patients with compound heterozygous or homozygous mutations in POMC exons develop early-onset obesity, adrenal insufficiency, and red hair pigmentation, establishing POMC as a monogenic determinant of energy homeostasis, adrenal function, and skin/hair pigmentation in humans.\",\n      \"method\": \"POMC gene sequencing in patients; identification of mutations (G7013T, C7133Δ in exon 3; C3804A in exon 2) that impair ACTH and α-MSH synthesis or abolish POMC translation\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — loss-of-function mutations with defined molecular mechanism and specific multi-organ phenotypic readout; >1200 citations\",\n      \"pmids\": [\"9620771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The Arg151Cys variant of human MC1R binds α-MSH with normal affinity but cannot be stimulated to produce cAMP, rendering MC1R completely nonfunctional and explaining red hair, light skin, and poor tanning ability in affected individuals.\",\n      \"method\": \"Receptor binding with 131I-α-MSH; cAMP functional assay in transfected cells expressing Arg151Cys MC1R vs. wild-type\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — binding vs. signaling dissociation by site-specific natural mutation, functionally validated in vitro\",\n      \"pmids\": [\"9571181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Desacetyl-α-MSH activates MC1, MC3, MC4, and MC5 receptors (EC50 0.13–0.84 nM) with comparable or greater potency to α-MSH; mouse agouti protein antagonizes desacetyl-α-MSH coupling to MC4R much more effectively than α-MSH coupling (with reduced Bmax and increased EC50), revealing differential antagonism depending on the N-terminal acetylation state of the ligand.\",\n      \"method\": \"Stable expression of individual MCRs in HEK293 cells; PKA signaling pathway assay; competitive antagonism with agouti protein\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — receptor pharmacology with quantitative dose-response and competitive antagonism analysis across multiple MCR subtypes\",\n      \"pmids\": [\"10218968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Several common MC1R point mutations (Val60Leu, Arg142His, Arg151Cys, Arg160Trp, Asp294His) found in red-haired individuals lose the ability to stimulate cAMP in response to α-MSH without complete loss of ligand binding (Arg142His and Asp294His show slight reduction in binding affinity), demonstrating loss-of-function at the signaling level.\",\n      \"method\": \"Transfection of mutant MC1R constructs in COS-1 cells; radioligand binding; cAMP production assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis panel with binding and signaling assays; multiple mutants tested\",\n      \"pmids\": [\"10403794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Chicken POMC gene was isolated as a single-copy gene with the same structural organization as mammalian POMC; the predicted 251 aa POMC contains nine proteolytic cleavage sites and can give rise to all melanocortin family members (ACTH, α-, β-, γ-MSH) and β-endorphin; POMC mRNA is expressed in brain, adrenal gland, gonads, kidney, uropygial gland, and adipose tissue.\",\n      \"method\": \"Genomic library screening, molecular cloning, sequence analysis, RT-PCR expression profiling\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gene cloning with sequence-predicted cleavage sites confirmed by comparative analysis; ortholog study\",\n      \"pmids\": [\"10395956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"A missense mutation R236G in POMC disrupts the dibasic cleavage site between β-MSH and β-endorphin; cells transfected with mutant POMC produce a β-MSH/β-endorphin fusion protein that binds hMC4R with normal affinity but has markedly reduced ability to activate it, establishing a novel mechanism of obesity susceptibility through production of an aberrant POMC product that interferes with melanocortin signaling.\",\n      \"method\": \"POMC gene sequencing in 262 obese subjects; transfection of mutant POMC cDNA in β-TC3 cells; metabolic labeling; receptor binding and cAMP assay with hMC4R\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutant protein production confirmed biochemically, receptor binding vs. activation dissection in vitro, co-segregation in family\",\n      \"pmids\": [\"12165561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Leptin stimulates POMC gene transcription via activation of STAT3; leptin-induced POMC promoter activity requires the STAT3-binding site (Tyr1138) of the leptin receptor ObRb and a defined 30-bp promoter element; approximately 37% of hypothalamic POMC neurons (concentrated in the rostral region) show leptin-induced STAT3 phosphorylation.\",\n      \"method\": \"POMC promoter reporter assays in transfected cells; dominant-negative STAT3 expression; ObRb Tyr1138 mutant; double immunohistochemistry for phospho-STAT3 and POMC in rat hypothalamus\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (reporter assay, dominant negative, mutant receptor, in vivo immunohistochemistry) in two systems\",\n      \"pmids\": [\"12697721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"α-MSH and desacetyl-α-MSH similarly couple overexpressed MC1, MC3, MC4, and MC5 receptors to both adenylyl cyclase and calcium signaling pathways in HEK293 cells; however, α-MSH (but not desacetyl-α-MSH) significantly increases primary rat osteoblast proliferation, revealing a functional divergence at endogenous (low) receptor expression levels.\",\n      \"method\": \"Stably expressed MCRs in HEK293 cells; adenylyl cyclase assay; calcium signaling assay; primary osteoblast proliferation assay\",\n      \"journal\": \"Annals of the New York Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two signaling pathways measured with multiple MCR subtypes; divergent result in primary cells with endogenous receptors\",\n      \"pmids\": [\"12851298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"NPY inhibits posttranslational processing of POMC to active α-MSH by reducing prohormone convertase-2 (PC2) levels in ARC neurons; this is mediated through NPY-Y1 receptors and the transcription factor Egr-1. NPY also decreases α-MSH-induced CREB phosphorylation in the PVN, reducing TRH production, and decreases the amount of α-MSH delivered to PVN neurons.\",\n      \"method\": \"In vivo NPY injection; PC2 mRNA and protein measurements; Egr-1 knockdown; CREB phosphorylation assay; α-MSH and TRH measurements in hypothalamic nuclei\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vivo and molecular assays identifying a post-translational processing mechanism\",\n      \"pmids\": [\"23321476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CRH stimulates cAMP, POMC gene expression, ACTH production and release, and corticosterone production in human dermal fibroblasts (but not keratinocytes), demonstrating a functional cutaneous CRH-POMC-corticosteroid axis equivalent to the HPA axis.\",\n      \"method\": \"Primary human fibroblast and keratinocyte cultures; cAMP assay; POMC mRNA and protein measurement; ELISA for corticosterone\",\n      \"journal\": \"Journal of neuroimmunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple assays (cAMP, mRNA, protein, hormone output) in primary human cells with appropriate cell-type controls\",\n      \"pmids\": [\"15833364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LXRα positively regulates the POMC gene promoter at the transcriptional level; the RXRα/LXRα heterodimer binds the region between -73 and -52 bp of the rat POMC promoter; LXR agonist TO901317 increased POMC mRNA, ACTH immunoreactivity in pituitary, and plasma ACTH/corticosterone in vivo.\",\n      \"method\": \"Luciferase reporter assay; siRNA knockdown of LXRα; EMSA (electrophoretic mobility shift assay); chromatin immunoprecipitation (ChIP); in vivo mouse experiments\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — EMSA with specific binding site mutants, ChIP confirmation, functional reporter assay, and in vivo validation\",\n      \"pmids\": [\"19036902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Two novel heterozygous missense mutations in the POMC N-terminus (C28F and L37F) impair sorting of POMC to the regulated secretory pathway, redirecting mutant POMC to the constitutive secretory pathway, thereby preventing normal propeptide processing to bioactive melanocortin products and causing early-onset obesity.\",\n      \"method\": \"Metabolic labeling, Western blotting, immunoassay of lysates and conditioned media of transiently transfected β-TC3 cells; comparison of wild-type vs. mutant POMC processing and secretion\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mechanistic in vitro experiments with metabolic labeling and secretion analysis distinguishing regulated vs. constitutive pathways\",\n      \"pmids\": [\"18697863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"POMC neuron-specific deletion of PTP1B reduces adiposity, improves leptin sensitivity, and increases energy expenditure on high-fat diet; POMC neuron-specific deletion of SHP2 produces opposite effects (increased adiposity, decreased leptin sensitivity, reduced energy expenditure) and markedly reduces hypothalamic POMC mRNA and α-MSH peptide levels, demonstrating that PTP1B and SHP2 reciprocally regulate energy balance via POMC neurons.\",\n      \"method\": \"Conditional (Cre-lox) POMC neuron-specific knockout mice for Ptp1b and Shp2; body composition measurement; hyperinsulinemic-euglycemic clamp; hypothalamic POMC mRNA and α-MSH peptide quantification\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal genetic loss-of-function with multiple metabolic and molecular phenotypic readouts\",\n      \"pmids\": [\"20160350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Pharmacogenetic (DREADD) activation of NTS POMC neurons acutely inhibits feeding within minutes, while ARC POMC neurons require chronic stimulation to suppress food intake; ablation of ARC but not NTS POMC neurons with diphtheria toxin increases food intake, reduces energy expenditure, and causes obesity and endocrine disorders, demonstrating distinct temporal and functional roles for POMC neurons in the two brain regions.\",\n      \"method\": \"Cre-dependent AAV delivery of hM3Dq DREADD or diphtheria toxin receptor to ARC vs. NTS POMC neurons in POMC-Cre mice; clozapine-N-oxide administration; diphtheria toxin ablation; food intake and energy expenditure measurement\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — DREADD activation and toxin-mediated ablation with specific stereotaxic targeting, multiple metabolic phenotypes measured\",\n      \"pmids\": [\"23426689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MeCP2 positively regulates hypothalamic Pomc expression by preventing promoter DNA hypermethylation; deletion of MeCP2 in POMC neurons increases DNA methylation of the Pomc promoter and reduces POMC expression, causing obesity and leptin resistance. In vitro, hypermethylation of the Pomc promoter reduces transcriptional activity, and MeCP2 acts synergistically with CREB1 to activate the Pomc promoter.\",\n      \"method\": \"POMC-neuron-specific MeCP2 knockout mice; bisulfite sequencing of Pomc promoter; luciferase reporter assay with methylated promoter; co-transfection with MeCP2 and CREB1; metabolic phenotyping\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with methylation mapping, in vitro reporter assays, and metabolic phenotyping; multiple orthogonal methods\",\n      \"pmids\": [\"24078059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Early-life stress (maternal separation) reduces DNA methylation at a critical regulatory region (-417 to -260 bp) of the Pomc promoter in mouse pituitary, leading to increased Pomc mRNA that persists for up to 1 year. Methyl-CpG binding protein-2 (MeCP2) binds the distal Pomc promoter and acts with HDAC2 and DNMT1 to repress Pomc expression under basal conditions.\",\n      \"method\": \"Early-life stress model in mice; bisulfite sequencing; MeCP2 binding assay; AtT20 cell line with site-specific Pomc promoter methylation; co-immunoprecipitation of MeCP2 with HDAC2 and DNMT1\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo epigenetic analysis, confirmed in pituitary cell line with site-specific methylation and protein interaction studies\",\n      \"pmids\": [\"24506071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FoxO1 inhibits STAT3-mediated leptin induction of POMC transcription through direct protein-protein interaction with STAT3; residues Gly140-Leu160 (specifically Gln145, Arg147, Lys148, Arg153, Arg154) of FoxO1 are critical for STAT3 binding; FoxO3 (but not FoxO4) similarly interacts with STAT3 and inhibits POMC promoter activity.\",\n      \"method\": \"Co-immunoprecipitation; FoxO1 deletion mutant analysis; POMC promoter luciferase assay; STAT3 binding mutants; computational docking simulation\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — biochemical interaction mapping with deletion and point mutants, functional promoter assay, and structural modeling\",\n      \"pmids\": [\"25510553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GPR45 regulates POMC expression via the JAK/STAT signaling pathway in a cell-autonomous manner; disruption of Gpr45 in mice reduces POMC expression and energy expenditure; intraventricular melanotan-2 (α-MSH analog) rescues adult obesity in Gpr45 mutants, placing GPR45 upstream of POMC in the melanocortin energy-balance pathway.\",\n      \"method\": \"piggyBac insertional mutagenesis screen; conditional Gpr45 disruption; POMC expression measurement; JAK/STAT pathway analysis; intracerebroventricular drug administration; metabolic phenotyping\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with pathway analysis (JAK/STAT), cell-autonomous validation, and pharmacological rescue\",\n      \"pmids\": [\"27500489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Hypothalamic Kiss1 (kisspeptin) neurons, which regulate fertility and puberty onset, arise developmentally from POMC-expressing progenitors; using intersectional ribosome-tagging strategies in mice, Pomc-expressing precursors were shown to give rise to both energy-sensing POMC/AgRP neurons and reproductive Kiss1 neurons.\",\n      \"method\": \"Intersectional Cre-lox (embryonic and adult ribosome-tagging) transgenic mouse strategy; lineage tracing from Pomc-expressing progenitors; cell-type specific translational profiling\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic lineage tracing with dual reporter strategy, clean developmental pathway assignment\",\n      \"pmids\": [\"25855171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Metformin induces AMPK/LXRα phosphorylation followed by suppression of POMC expression in rat pituitary cells, leading to reduced ACTH and cortisol levels; this AMPK/LXRα/POMC pathway was confirmed in animal studies as a molecular mechanism underlying the antihyperglycemic effect of metformin.\",\n      \"method\": \"Urinary metabolomics in human subjects; in vitro rat pituitary cell treatment with metformin; AMPK and LXRα phosphorylation assays; POMC/ACTH measurement; in vivo rat experiments\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo mechanistic evidence but single lab; pathway confirmed with phosphorylation assays\",\n      \"pmids\": [\"25634597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"E2F1 (phosphorylated at Ser-337) binds a cluster site in the proximal hPOMC promoter region (-42 to +68) and, together with its heterodimer partner DP1, drives ectopic hPOMC transcription in non-pituitary tumor cells independently of pituitary-specific Tpit/Pitx1 factors; inhibitors of E2F1 suppressed hPOMC expression and ACTH in vitro and in xenografted mice.\",\n      \"method\": \"POMC promoter reporter assays; E2F1/DP1 co-expression; ChIP for E2F1 binding; phosphorylation analysis (Ser-337); E2F1 inhibitors; xenograft mouse model; primary tumor cells\",\n      \"journal\": \"Endocrine-related cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with promoter reporter assays and in vivo xenograft validation, multiple orthogonal methods\",\n      \"pmids\": [\"27935805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Glutamatergic ARC neurons expressing the oxytocin receptor rapidly cause satiety when optogenetically/chemogenetically activated; their projections converge with GABAergic AgRP projections on MC4R-expressing PVH neurons (PVHMC4R). Transmission across the ARCGlutamatergic→PVHMC4R synapse is potentiated by α-MSH (derived from ARCPOMC neurons) acting as an MC4R agonist, revealing post-synaptic modulation of a satiety circuit by POMC-derived α-MSH.\",\n      \"method\": \"Optogenetics and chemogenetics (DREADD); electrophysiology; circuit tracing; MC4R-Cre conditional mouse lines; synaptic physiology recording before and after α-MSH application\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal circuit-tracing, optogenetic, and electrophysiological approaches; α-MSH role confirmed with pharmacology\",\n      \"pmids\": [\"27869800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"IRE1α in POMC neurons is required for thermogenesis and glycemia; POMC-specific Ire1α deficiency accelerates diet-induced obesity, impairs thermogenic responses and beiging of white adipose tissue, and causes whole-body glucose and insulin intolerance and hepatic insulin resistance; loss of Ire1α elevates ER stress and promotes leptin and insulin resistance in POMC neurons.\",\n      \"method\": \"Conditional Ire1α knockout in POMC neurons; metabolic phenotyping (energy expenditure, glucose/insulin tolerance tests, hepatic insulin sensitivity); hypothalamic ER stress markers\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean cell-type-specific genetic KO with multiple metabolic and cellular phenotypic endpoints\",\n      \"pmids\": [\"28028078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TrpC5 channel subunits in POMC neurons mediate the acute anorexigenic effects of leptin and serotonin 2C receptor agonists; POMC-specific or neuronal TrpC5 deletion reduces energy expenditure, increases food intake, and blunts electrophysiological responses of arcuate POMC neurons to leptin and 5-HT2CR agonists, and blocks lorcaserin-induced glucose/insulin tolerance improvements.\",\n      \"method\": \"Conditional TrpC5 KO in POMC neurons; electrophysiology (patch-clamp) of arcuate POMC neurons; pharmacological challenge with leptin and 5-HT2CR agonist lorcaserin; metabolic phenotyping\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with electrophysiological and metabolic phenotyping; receptor pharmacology validated\",\n      \"pmids\": [\"28099839\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In diet-induced obese mice, persistently activated microglia hypersecrete TNFα which stimulates mitochondrial ATP production and fusion in POMC neuron neurites, increasing POMC neuronal firing rates and excitability; disruption of TNFα downstream signals TNFSF11A or NDUFAB1 in the mediobasal hypothalamus reverses mitochondrial elongation and reduces obesity.\",\n      \"method\": \"Diet-induced obesity mouse model; microglial activation characterization; TNFα measurement; mitochondrial morphology imaging in POMC neurons; electrophysiology; targeted gene disruption (TNFSF11A, NDUFAB1)\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway from microglia→TNFα→mitochondrial fusion→POMC excitability, multiple orthogonal methods\",\n      \"pmids\": [\"28489068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DRP1-mediated mitochondrial fission in POMC neurons restrains leptin sensitivity and glucose sensing; inducible deletion of DRP1 in mature POMC neurons increases mitochondrial size, ROS production, and neuronal activation, improves leptin sensitivity and glucose responsiveness, and enhances glucoprivic counter-regulatory responses via PPAR-dependent upregulation of Kcnj11 (KATP channel subunit).\",\n      \"method\": \"Inducible conditional DRP1 KO in POMC neurons (Drp1fl/fl-POMC-cre:ERT2); mitochondrial morphology analysis; electrophysiology; leptin and glucose challenge assays; gene expression (Kcnj11, PPAR pathway)\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible conditional KO with mechanistic follow-up (ROS, PPAR pathway, Kcnj11) and electrophysiological readout\",\n      \"pmids\": [\"28190775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ATF4 in POMC neurons directly binds the ATG5 promoter and represses ATG5 transcription; loss of ATF4 in POMC neurons upregulates ATG5-dependent macroautophagy and increases α-MSH production in the hypothalamus, leading to a lean phenotype resistant to diet-induced obesity. Double KO of Atf4 and Atg5 in POMC neurons reverses the lean phenotype, placing ATG5/autophagy downstream of ATF4 as a mechanism regulating α-MSH production.\",\n      \"method\": \"POMC-neuron-specific Atf4 KO; double Atf4/Atg5 KO; ATF4 ChIP at ATG5 promoter; autophagy flux assays; α-MSH measurement; metabolic phenotyping\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis by double KO, ChIP for direct promoter binding, functional α-MSH output assay\",\n      \"pmids\": [\"28350524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A subpopulation of POMC neurons is activated by insulin via insulin receptor signaling, and represses hepatic glucose production (HGP); the proportion of POMC neurons activated by insulin is regulated by the phosphatase TCPTP, which is increased by fasting and degraded after feeding. Elevated TCPTP in obesity represses insulin-induced activation of POMC neurons and their ability to suppress HGP.\",\n      \"method\": \"POMC-neuron-specific TCPTP deletion in mice; electrophysiology of POMC neurons; hepatic glucose production measurement (hyperinsulinemic-euglycemic clamp); TCPTP protein level analysis in obesity and fasting/fed states\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with electrophysiology, clamp studies, and mechanistic TCPTP regulation defined\",\n      \"pmids\": [\"30230471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"POMCLepr+ and POMCGlp1r+ neuron subpopulations in the arcuate nucleus are largely nonoverlapping, exhibit distinct electrophysiological properties and anatomical distributions, differentially express receptors for energy-state hormones and neurotransmitters, and differ in their ability to suppress feeding, revealing a functional microarchitecture of POMC neurons.\",\n      \"method\": \"Intersectional Cre/Dre-dependent mouse models for labeling specific POMC subpopulations; translational profiling (RiboTag); electrophysiology; chemogenetic feeding assays\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — intersectional genetic approach with electrophysiology, transcriptomics, and functional feeding assays across two distinct subpopulations\",\n      \"pmids\": [\"34002087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"mTORC1 blockade in POMC neurons induces hyperphagia by mimicking a cellular negative energy state; this is associated with decreased α-MSH production, recruitment of POMC/GABAergic neurotransmission (restrained by cannabinoid type 1 receptor), and simultaneous activation of POMC/GABAergic neurons and inhibition of POMC/glutamatergic neurons, revealing mTORC1 as an orchestrator of functionally distinct POMC neuron subpopulations.\",\n      \"method\": \"Conditional mTORC1 (Raptor) KO in POMC neurons; chemogenetics; electrophysiology; optogenetics; α-MSH measurement; translational profiling and single-cell analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (conditional KO, chemogenetics, optogenetics, electrophysiology, α-MSH assay)\",\n      \"pmids\": [\"34644574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In diabetic mice, NF-κB p50 subunit binding to the Pomc promoter represses POMC expression in sensory neurons; decreased POMC leads to lysosomal degradation of μ-opioid receptor (MOR), impairing antinociception; viral overexpression of POMC and MOR in sensory ganglia rescues the neuropathic pain phenotype.\",\n      \"method\": \"Streptozotocin diabetic mouse model; ChIP for NF-κB p50 at Pomc promoter; peripheral nerve POMC level measurement; MOR degradation analysis; AAV-mediated overexpression of POMC and MOR in sensory ganglia; behavioral pain assays; validation in human diabetic peripheral nervous system tissue\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP identifies molecular mechanism (NF-κB p50 repression), validated in vivo by viral rescue, and corroborated in human tissue\",\n      \"pmids\": [\"33462216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"L-Lactate activates hypothalamic POMC neurons via two mechanisms: (1) through HCAR1 (hydroxycarboxylic acid receptor 1) on astrocytes coupled to Gαi/o-protein, mediating intercellular signaling to POMC neurons; and (2) via intracellular action blocked by the lactate transporter inhibitor 4-CIN in a subset of POMC neurons; depolarization in both cases is pertussis toxin-sensitive.\",\n      \"method\": \"Patch-clamp electrophysiology of labeled POMC neurons; pharmacological dissection with PTX, 4-CIN, APJ receptor antagonist, HCAR1 agonist 3Cl-HBA; immunohistochemical localization of HCAR1 to astrocytes not POMC neurons\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology with pharmacological dissection; novel mechanism (astrocyte HCAR1→POMC neuron signaling) identified but single lab\",\n      \"pmids\": [\"34737351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Optogenetic activation of the ARCPOMC→MeA (medial amygdala) neural projection reduces short-term food intake; anterograde tracing shows ARC POMC neurons project to ER-α- and MC4R-expressing neurons in the MeA; the anorectic effect of ARCPOMC→MeA stimulation is blocked by the MC4R antagonist SHU9119, establishing a functional extrahypothalamic melanocortinergic satiety circuit.\",\n      \"method\": \"Optogenetics (ChR2); monosynaptic anterograde and retrograde viral tracing; double immunohistochemistry for MC4R and ER-α; MC4R antagonist pharmacology; food intake measurement\",\n      \"journal\": \"Frontiers in neural circuits\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — optogenetics combined with circuit tracing and pharmacological validation\",\n      \"pmids\": [\"33250721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Apelin-13 depolarizes approximately half of arcuate POMC neurons in a dose-dependent manner via the APJ receptor; this effect is mediated by Gβγ-dependent activation of PLC-β signaling (not Gαi/o) that inhibits M-type current (KCNQ channels 2, 3, 5); pertussis toxin does not block the response, but the Gβγ inhibitor gallein and PLC/PKC inhibitors do.\",\n      \"method\": \"Electrophysiology (patch-clamp); single-cell qPCR for APJ receptor and KCNQ subunits; pharmacological dissection with APJ antagonist, pertussis toxin, gallein, PLC/PKC inhibitors; M-current measurement\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology with rigorous pharmacological dissection and single-cell receptor expression confirmation\",\n      \"pmids\": [\"25782002\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POMC is a precursor polypeptide processed in a tissue-specific manner by prohormone convertases at dibasic cleavage sites to generate biologically active melanocortin peptides (α-, β-, γ-MSH, ACTH) and β-endorphin; POMC transcription is driven by tissue-specific regulators (Tpit/Pitx1 in pituitary, E2F1 in ectopic tumors), stimulated by CRF/STAT3/LXRα/leptin-STAT3 signaling, and repressed by glucocorticoids via an nGRE and by FoxO1-mediated blockade of STAT3, DNA methylation (regulated by MeCP2 and NF-κB p50), and ATF4; in hypothalamic POMC neurons, hormonal inputs (leptin via STAT3, insulin via IR/TCPTP, serotonin via TrpC5, apelin via APJ/Gβγ/KCNQ, lactate via astrocyte HCAR1) converge on neuronal excitability to control energy homeostasis through release of α-MSH that activates MC3R/MC4R on downstream neurons (including in the PVH and MeA) to suppress feeding, while mitochondrial dynamics (DRP1-dependent fission, TNFα-driven fusion) and mTORC1 within functionally distinct POMC neuron subpopulations further tune their activity and neurotransmitter output.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"POMC encodes a precursor polypeptide that undergoes tissue-specific proteolytic processing to yield melanocortins (ACTH, α-MSH, β-MSH, γ-MSH) and β-endorphin, with differential sorting of these peptides into distinct secretory granule populations in pituitary corticotropes [PMID:3004731, PMID:2836169]. In hypothalamic arcuate nucleus (ARC) neurons, POMC-derived α-MSH acts as an MC4R agonist to suppress feeding via projections to the paraventricular hypothalamus and medial amygdala, with functionally heterogeneous POMC neuron subpopulations (POMCLepr+, POMCGlp1r+, glutamatergic, GABAergic) differentially regulated by leptin (via STAT3/FoxO1/SHP2), insulin (gated by TCPTP), mTORC1, mitochondrial dynamics (DRP1), and ion channels including TrpC5 and KCNQ [PMID:34002087, PMID:34644574, PMID:20160350, PMID:30230471, PMID:28190775, PMID:28099839]. POMC transcription is controlled by a negative glucocorticoid response element and COUP factors in the proximal promoter, LXR-α/RXR-α binding, E2F1/DP1-driven ectopic expression, and epigenetic regulation through CpG methylation and MeCP2/HDAC2 repressor complexes [PMID:2698828, PMID:19036902, PMID:27935805, PMID:24506071]. Missense mutations in the POMC N-terminal signal region (C28F, L37F) redirect POMC from the regulated to the constitutive secretory pathway, impairing bioactive peptide production and causing obesity [PMID:18697863].\",\n  \"teleology\": [\n    {\n      \"year\": 1974,\n      \"claim\": \"Structure–activity analysis of ACTH established that Trp-9 is required for adrenal adenylate cyclase activation despite being dispensable for receptor binding, separating ligand-receptor binding from effector coupling for POMC-derived peptides.\",\n      \"evidence\": \"Synthetic ACTH analogs tested on bovine adrenal cortical membrane adenylate cyclase assay\",\n      \"pmids\": [\"4359333\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for Trp-9 requirement not resolved\", \"Applicability to melanocortin receptors beyond MC2R not tested\"]\n    },\n    {\n      \"year\": 1986,\n      \"claim\": \"Dual-label immunoelectron microscopy revealed that ACTH and α-MSH are sorted into distinct secretory granule populations within pituitary corticotropes, establishing that POMC processing products are differentially compartmentalized at the subcellular level.\",\n      \"evidence\": \"Double-label ferritin/colloidal gold immunoEM in rat anterior pituitary\",\n      \"pmids\": [\"3004731\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular sorting signals not identified\", \"Only two peptide products examined\", \"Single study without independent replication\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Detection of a shorter POMC mRNA and immunoreactive POMC-derived peptides in multiple non-pituitary tissues demonstrated widespread extra-pituitary POMC expression, expanding the gene's functional scope beyond the HPA axis.\",\n      \"evidence\": \"Northern blot with exon 3 riboprobe, RIA, and gel filtration across rat tissues\",\n      \"pmids\": [\"2836169\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of processing enzymes in peripheral tissues not determined\", \"Functional significance of extra-pituitary POMC peptides remained unclear\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Identification of a negative glucocorticoid response element (nGRE) and COUP factor binding in the POMC promoter revealed the mechanism of glucocorticoid-mediated transcriptional repression and tissue-specific regulation.\",\n      \"evidence\": \"Transgenic mice and cell transfection with promoter fragments; EMSA for protein–DNA binding\",\n      \"pmids\": [\"2698828\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise mechanism of mutually exclusive GR/COUP binding not structurally resolved\", \"Hypothalamic promoter regulation not addressed\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"UVB radiation was shown to stimulate POMC expression and α-MSH/ACTH release in skin cells via cAMP and oxidative stress pathways, establishing a cutaneous POMC-melanocortin stress-response system.\",\n      \"evidence\": \"Cell culture with UVB, cAMP agonist, IL-1α, and NAC; RIA for peptide secretion in melanocytes and keratinocytes\",\n      \"pmids\": [\"8781560\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcription factor mediating UVB-induced POMC expression not identified\", \"In vivo relevance in human skin not demonstrated\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Two advances clarified POMC regulation: CRH was shown to drive a functional local CRH→POMC→corticosteroid axis in dermal fibroblasts, and POMC promoter CpG methylation at the E2F-binding region was linked to ectopic POMC overexpression in thymic carcinoids.\",\n      \"evidence\": \"cAMP/ELISA assays in fibroblasts vs. keratinocytes; bisulfite sequencing of POMC promoter in tumors vs. normal thymus\",\n      \"pmids\": [\"15833364\", \"15845926\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"CRH receptor subtype mediating fibroblast axis not specified\", \"Causal role of hypomethylation in ectopic expression not experimentally proven\", \"Each finding from single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Two studies revealed distinct regulatory layers: N-terminal POMC missense mutations (C28F, L37F) in obese patients were shown to redirect POMC from regulated to constitutive secretory pathway, and LXR-α/RXR-α was identified as a direct positive transcriptional regulator binding the POMC promoter.\",\n      \"evidence\": \"Metabolic labeling/Western blot in β-TC3 cells for sorting; EMSA/ChIP/siRNA/reporter assays in pituitary cell lines and in vivo for LXR-α\",\n      \"pmids\": [\"18697863\", \"19036902\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for signal peptide mutation effects on sorting unknown\", \"Physiological LXR-α ligand in pituitary not identified\", \"Whether LXR-α regulates hypothalamic POMC not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"POMC neuron-specific conditional knockouts demonstrated that SHP2 positively and PTP1B negatively regulate leptin sensitivity and α-MSH production, establishing opposing phosphatase control of melanocortin neuron function.\",\n      \"evidence\": \"Conditional KO mice with metabolic phenotyping, clamp studies, and hypothalamic POMC mRNA/peptide measurements\",\n      \"pmids\": [\"20160350\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct SHP2 substrates in POMC neurons not identified\", \"Interaction between PTP1B and SHP2 pathways not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"NPY was found to inhibit POMC-to-α-MSH conversion by suppressing PC2 expression via Y1R/Egr-1 signaling, revealing a post-translational mechanism by which the orexigenic system antagonizes melanocortin output.\",\n      \"evidence\": \"Pharmacological NPY/Y1R antagonism with PC2 mRNA/protein measurement and α-MSH quantification in rat hypothalamus\",\n      \"pmids\": [\"23321476\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Egr-1 directly binds the PC2 promoter not shown by ChIP\", \"Relevance under physiological NPY release not confirmed\", \"Single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Epigenetic regulation of POMC was mechanistically defined: MeCP2 binds the Pomc promoter with HDAC2/DNMT1 to repress transcription, and loss of MeCP2 specifically in POMC neurons increases promoter methylation, reduces POMC expression, and causes obesity and leptin resistance.\",\n      \"evidence\": \"Bisulfite sequencing, EMSA, luciferase assays, and conditional MeCP2 KO mice with metabolic phenotyping\",\n      \"pmids\": [\"24506071\", \"24078059\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific CpG sites are critical for MeCP2-mediated repression not fully mapped\", \"Paradoxical increase in methylation upon MeCP2 loss mechanistically unexplained\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"FoxO1 was shown to inhibit leptin-induced POMC transcription by both direct promoter binding and physical interaction with STAT3 (via residues 140–160), preventing STAT3 from engaging SP1 on the POMC promoter; apelin-13 was separately shown to depolarize POMC neurons via APJ/Gβγ/PLCβ-mediated inhibition of KCNQ channels.\",\n      \"evidence\": \"Co-IP/mutagenesis/reporter assays for FoxO1-STAT3; patch-clamp with pharmacological dissection and single-cell qPCR for apelin signaling\",\n      \"pmids\": [\"25510553\", \"25782002\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"FoxO1-STAT3 interaction not validated in vivo in POMC neurons\", \"Endogenous apelin source activating POMC neurons unknown\", \"Each finding from single lab\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Multiple studies defined new regulatory inputs to POMC neurons: E2F1/DP1 was identified as a driver of ectopic POMC transcription in non-pituitary tumors; IRE1α was shown to be required for POMC neuron thermogenesis and hormone sensitivity; GPR45 was found to regulate POMC expression via JAK/STAT; and ARC→PVH MC4R circuit was mapped for satiety modulation by α-MSH.\",\n      \"evidence\": \"ChIP/reporter/xenograft for E2F1; conditional KO with metabolic phenotyping for IRE1α and GPR45; optogenetics/chemogenetics/electrophysiology for circuit\",\n      \"pmids\": [\"27935805\", \"28028078\", \"27500489\", \"27869800\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E2F1 phosphorylation kinase in tumors not identified\", \"IRE1α downstream effectors in POMC neurons (XBP1 vs. RIDD) not distinguished\", \"GPR45 endogenous ligand unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Mitochondrial dynamics, ion channels, and autophagy were linked to POMC neuron output: DRP1-mediated fission regulates leptin sensitivity and glucose sensing; TrpC5 channels are required for leptin and serotonergic activation; ATF4→ATG5 autophagy pathway controls α-MSH production; and microglial TNFα drives mitochondrial fusion in POMC neurites during obesity.\",\n      \"evidence\": \"Inducible conditional KOs (DRP1, TrpC5, ATF4, ATF4/ATG5 double KO) with electrophysiology, metabolic phenotyping, and mitochondrial imaging\",\n      \"pmids\": [\"28190775\", \"28099839\", \"28350524\", \"28489068\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How DRP1-dependent ROS increase enhances leptin sensitivity mechanistically unclear\", \"Whether TrpC5 is directly gated by leptin receptor signaling not resolved\", \"ATF4-ATG5 epistasis demonstrated only in vivo, not reconstituted biochemically\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"TCPTP was identified as a fasting-induced phosphatase that limits insulin activation of POMC neurons; its degradation after feeding permits insulin signaling, establishing TCPTP as a metabolic state-dependent switch controlling POMC neuron responsiveness and hepatic glucose production.\",\n      \"evidence\": \"Conditional KO mice; electrophysiology; hyperinsulinemic-euglycemic clamp\",\n      \"pmids\": [\"30230471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Proteasomal vs. lysosomal mechanism of TCPTP degradation after feeding not defined\", \"Whether TCPTP and PTP1B act on same substrates in POMC neurons unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Optogenetic activation of ARC POMC projections to the medial amygdala was shown to reduce food intake via MC4R, revealing a novel extrahypothalamic melanocortinergic satiety circuit targeting ERα+/MC4R+ MeA neurons.\",\n      \"evidence\": \"Viral tracing, optogenetics, and pharmacological MC4R blockade\",\n      \"pmids\": [\"33250721\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether this circuit contributes to long-term weight regulation not tested\", \"Peptide release dynamics at MeA terminals not measured\", \"Single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Multiple discoveries resolved POMC neuron heterogeneity and additional regulatory inputs: intersectional genetics revealed functionally distinct POMCLepr+ and POMCGlp1r+ subpopulations; mTORC1 was shown to orchestrate the balance between melanocortinergic and GABAergic POMC outputs; lactate/HCAR1 astrocyte-to-neuron signaling was found to depolarize POMC neurons; and NF-κB p50-mediated POMC promoter repression plus MOR degradation were linked to diabetic neuropathy.\",\n      \"evidence\": \"Intersectional Cre/Dre genetics with electrophysiology and chemogenetics; conditional mutagenesis and optogenetics for mTORC1; patch-clamp pharmacology for lactate; ChIP and viral rescue in diabetic mice for NF-κB/MOR\",\n      \"pmids\": [\"34002087\", \"34644574\", \"34737351\", \"33462216\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular markers fully distinguishing all POMC subpopulations not yet established\", \"Whether mTORC1-dependent switch operates in human POMC neurons unknown\", \"Endogenous lactate flux to ARC POMC neurons in vivo not quantified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: how the full complement of POMC neuron subpopulations map onto distinct circuit functions and metabolic outputs; the structural basis by which signal-peptide mutations redirect POMC sorting; and whether the peripheral (skin, sensory neuron) POMC systems are therapeutically targetable independently of central melanocortin circuits.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Complete single-cell molecular taxonomy of POMC neurons with circuit-function mapping lacking\", \"No structural model of POMC sorting determinants\", \"Therapeutic modulation of peripheral POMC axes not tested in clinical trials\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [20, 25, 27]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [20, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 6, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 5, 12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 14, 20, 25, 27]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [15, 16, 20, 21, 22, 24, 25, 26]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 6, 7, 8, 9, 10]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"MC4R\",\n      \"STAT3\",\n      \"FOXO1\",\n      \"MECP2\",\n      \"E2F1\",\n      \"SHP2\",\n      \"PC2\",\n      \"TCPTP\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"POMC encodes a polyprotein precursor that is proteolytically processed at dibasic cleavage sites by prohormone convertases in a tissue-specific manner to yield melanocortin peptides (ACTH, α-MSH, β-MSH, γ-MSH) and β-endorphin, which act through a family of five G-protein-coupled melanocortin receptors (MC1R–MC5R) to regulate adrenal steroidogenesis, skin/hair pigmentation, energy homeostasis, and nociception [PMID:6254047, PMID:1325670, PMID:8392067]. In hypothalamic arcuate nucleus POMC neurons, leptin–STAT3, insulin–IR/TCPTP, serotonin–TrpC5, and apelin–APJ/Gβγ/KCNQ signaling pathways converge on neuronal excitability and α-MSH release, which activates MC4R on downstream PVH and MeA neurons to suppress feeding and modulate hepatic glucose production [PMID:12697721, PMID:28099839, PMID:30230471, PMID:27869800, PMID:33250721]. POMC transcription is driven by Tpit/Pitx1 in the pituitary and by E2F1/DP1 in ectopic tumors, stimulated by CRF and LXRα, and repressed by glucocorticoids via an nGRE, by FoxO1 sequestration of STAT3, by NF-κB p50 binding, and by promoter DNA methylation modulated by MeCP2 [PMID:2698828, PMID:27935805, PMID:19036902, PMID:25510553, PMID:24078059, PMID:33462216]. Loss-of-function POMC mutations in humans cause early-onset obesity, adrenal insufficiency, and red hair pigmentation, confirming POMC as a monogenic determinant of energy balance, adrenal function, and pigmentation [PMID:9620771].\",\n  \"teleology\": [\n    {\n      \"year\": 1980,\n      \"claim\": \"Sequencing the human POMC gene revealed a single-gene precursor architecture with dibasic residue cleavage sites demarcating ACTH and β-lipotropin segments, establishing the structural basis for tissue-specific proteolytic processing into multiple bioactive peptides.\",\n      \"evidence\": \"Genomic DNA sequencing with heteroduplex analysis and comparison to bovine cDNA\",\n      \"pmids\": [\"6254047\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Processing enzymes not yet identified\", \"Tissue-specific processing rules not defined\"]\n    },\n    {\n      \"year\": 1983,\n      \"claim\": \"CRF was identified as a physiological stimulus of POMC-derived peptide secretion from anterior pituitary via adenylate cyclase, while dopamine inhibits intermediate lobe output, defining the hormonal inputs controlling POMC product release at the pituitary level.\",\n      \"evidence\": \"Primary culture of rat anterior and intermediate pituitary cells with cAMP assay and in vivo peptide measurements\",\n      \"pmids\": [\"6310240\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intracellular signaling cascade from CRF to POMC transcription not mapped\", \"Relative contribution of cAMP vs. other second messengers unclear\"]\n    },\n    {\n      \"year\": 1986,\n      \"claim\": \"Central administration of ACTH and α-MSH suppressed feeding and antagonized κ-opioid-stimulated intake, establishing the concept of opposing melanocortin–opioid systems in energy homeostasis before melanocortin receptors were cloned.\",\n      \"evidence\": \"Intracerebroventricular injection of melanocortin peptides in rats with behavioral food-intake measurement\",\n      \"pmids\": [\"3025825\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor identity unknown at the time\", \"Pharmacological approach cannot distinguish direct vs. indirect effects\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Identification of a negative glucocorticoid response element (nGRE) in the proximal POMC promoter, where mutually exclusive binding of the glucocorticoid receptor and COUP-family factors determines glucocorticoid repression and cell-specific expression, established the first cis-regulatory logic for POMC transcription.\",\n      \"evidence\": \"Promoter deletion analysis in transgenic mice and cell culture with DNA-protein binding assays\",\n      \"pmids\": [\"2698828\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of transcription factors driving pituitary-specific expression not defined\", \"Chromatin context of nGRE occupancy not addressed\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Cloning of MC1R–MC5R defined the receptor family through which POMC-derived melanocortins signal, each coupling to adenylyl cyclase/cAMP, and revealed tissue-specific receptor expression explaining how a single precursor generates diverse physiological outputs.\",\n      \"evidence\": \"Molecular cloning with heterologous expression, binding assays, and cAMP signaling in transfected cells\",\n      \"pmids\": [\"1325670\", \"8392067\", \"8463333\", \"8185570\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Non-cAMP signaling pathways of MCRs incompletely characterized\", \"Endogenous receptor stoichiometry and functional selectivity not addressed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of compound heterozygous/homozygous POMC mutations in patients with early-onset obesity, adrenal insufficiency, and red hair provided the first human genetic proof that POMC is essential for energy homeostasis, adrenal function, and pigmentation.\",\n      \"evidence\": \"POMC gene sequencing in patients with defined multi-organ phenotype\",\n      \"pmids\": [\"9620771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype-phenotype correlation across a range of POMC mutations incomplete\", \"Relative contribution of individual POMC products to each phenotype unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that R236G disrupts a dibasic cleavage site to produce an aberrant β-MSH/β-endorphin fusion protein that binds MC4R but cannot activate it revealed that impaired POMC processing—not just absence of POMC—can cause obesity through generation of a dominant-negative-like melanocortin product.\",\n      \"evidence\": \"Metabolic labeling and receptor binding/cAMP assay with mutant POMC in transfected β-TC3 cells\",\n      \"pmids\": [\"12165561\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Prevalence of processing-site mutations in broader obese populations unknown\", \"Whether the fusion protein acts as a true competitive antagonist in vivo is unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Leptin was shown to stimulate POMC transcription via STAT3, requiring Tyr1138 of the leptin receptor and a specific POMC promoter element, providing the molecular link between peripheral adiposity signals and hypothalamic melanocortin output.\",\n      \"evidence\": \"POMC promoter reporter assays, dominant-negative STAT3, ObRb mutant, and phospho-STAT3/POMC double immunohistochemistry in rat hypothalamus\",\n      \"pmids\": [\"12697721\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Only ~37% of POMC neurons showed leptin-STAT3 activation; identity and regulation of the non-responding majority unclear\", \"Other leptin-activated pathways in POMC neurons not dissected\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"N-terminal POMC mutations (C28F, L37F) were shown to redirect POMC from the regulated to the constitutive secretory pathway, preventing proper processing and causing obesity—establishing that signal-peptide-region integrity is required for POMC sorting to secretory granules.\",\n      \"evidence\": \"Metabolic labeling and Western blot of wild-type vs. mutant POMC secretion in β-TC3 cells\",\n      \"pmids\": [\"18697863\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Sorting receptor or chaperone that recognizes the POMC N-terminus not identified\", \"Whether constitutively secreted unprocessed POMC has any signaling activity is unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Epigenetic regulation of POMC was defined: MeCP2 prevents promoter DNA hypermethylation and cooperates with CREB1 to activate POMC transcription in hypothalamic neurons, while in pituitary, MeCP2 complexes with HDAC2/DNMT1 to repress POMC—revealing tissue-specific epigenetic gating of POMC expression.\",\n      \"evidence\": \"POMC-neuron-specific MeCP2 KO mice; bisulfite sequencing; luciferase assays with methylated promoter; co-IP of MeCP2/HDAC2/DNMT1 in pituitary cells\",\n      \"pmids\": [\"24078059\", \"24506071\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MeCP2 switches between activator and repressor roles in different tissues is mechanistically unresolved\", \"Contribution of other chromatin remodelers not assessed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"α-MSH was shown to act as a postsynaptic neuromodulator at MC4R-expressing PVH neurons, potentiating glutamatergic satiety transmission from ARC to PVH, and a separate ARCPOMC→MeA projection was identified as an extrahypothalamic melanocortinergic satiety circuit.\",\n      \"evidence\": \"Optogenetics, chemogenetics, electrophysiology, and MC4R antagonist pharmacology in circuit-specific mouse models\",\n      \"pmids\": [\"27869800\", \"33250721\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of PVH vs. MeA projection to overall satiety unclear\", \"Neuropeptide vs. fast neurotransmitter release from POMC neurons not fully dissected\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Mitochondrial dynamics within POMC neurons emerged as a cell-intrinsic rheostat: TNFα-driven mitochondrial fusion increases POMC neuron excitability in obesity, while DRP1-mediated fission restrains leptin sensitivity and glucose sensing, with mTORC1 orchestrating functionally distinct GABAergic and glutamatergic POMC neuron subpopulations.\",\n      \"evidence\": \"Conditional KO of DRP1 and Raptor in POMC neurons; microglial TNFα and mitochondrial morphology imaging; electrophysiology; optogenetics and chemogenetics\",\n      \"pmids\": [\"28489068\", \"28190775\", \"34644574\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How mitochondrial dynamics interface with POMC processing machinery is unknown\", \"Whether mitochondrial fission/fusion directly affects α-MSH vesicle packaging is untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Multiple ion channel and receptor mechanisms controlling POMC neuron excitability were defined: TrpC5 channels mediate leptin and serotonin 2C receptor-driven depolarization, while apelin acts via APJ/Gβγ/PLC-β to inhibit KCNQ M-type currents, establishing the electrophysiological integration point for diverse hormonal inputs.\",\n      \"evidence\": \"Conditional TrpC5 KO in POMC neurons with patch-clamp; pharmacological dissection of apelin signaling in POMC neurons with Gβγ inhibitor gallein and PLC/PKC inhibitors\",\n      \"pmids\": [\"28099839\", \"25782002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full ion channel repertoire of POMC neuron subpopulations not cataloged\", \"Whether TrpC5 and KCNQ pathways converge in the same POMC neurons is unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The phosphatase TCPTP was identified as a fasting/feeding-regulated brake on insulin signaling in POMC neurons: elevated in fasting and obesity, TCPTP dephosphorylates the insulin receptor to silence insulin-responsive POMC neurons and their suppression of hepatic glucose production.\",\n      \"evidence\": \"POMC-neuron-specific TCPTP deletion with electrophysiology and hyperinsulinemic-euglycemic clamp studies\",\n      \"pmids\": [\"30230471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"TCPTP targets beyond the insulin receptor in POMC neurons not mapped\", \"How TCPTP is degraded upon feeding is mechanistically undefined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Intersectional genetic approaches revealed that POMCLepr+ and POMCGlp1r+ neuron subpopulations are largely nonoverlapping, with distinct electrophysiological properties and differential capacity to suppress feeding, establishing a functional microarchitecture within the POMC neuron population.\",\n      \"evidence\": \"Intersectional Cre/Dre mouse models with RiboTag translational profiling, electrophysiology, and chemogenetic feeding assays\",\n      \"pmids\": [\"34002087\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full molecular taxonomy of POMC neuron subtypes across brain regions incomplete\", \"How subpopulation-specific outputs are integrated at downstream targets is undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include how POMC neuron subpopulation-specific neurotransmitter release (GABA vs. glutamate vs. α-MSH) is coordinately regulated, whether mitochondrial dynamics directly control POMC processing and peptide packaging, and the identity of sorting receptors that direct POMC to the regulated secretory pathway.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Sorting receptor for POMC into secretory granules not identified\", \"Structural basis of POMC–prohormone convertase interaction unknown\", \"Integration rules across POMC neuron subpopulations at downstream target neurons undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [4, 10, 11, 12, 14, 17, 20, 39]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [3, 16, 27, 29]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [3, 29]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [10, 11, 12, 14, 17, 20, 24, 39, 41, 51]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 23, 26, 29]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [5, 31, 39, 41, 46, 50]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [30, 40, 43, 45]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [16, 48]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"MC1R\",\n      \"MC3R\",\n      \"MC4R\",\n      \"STAT3\",\n      \"MeCP2\",\n      \"PCSK2\",\n      \"FOXO1\",\n      \"TRPC5\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}